The SAS System 1 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.BASELINE Observations: 1441 Member Type: DATA Variables: 81 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 470 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 40960 Number of Data Set Pages: 17 File Format: 607 First Data Page: 1 Max Obs per Page: 87 Obs in First Data Page: 65 File Name: /home/squid/will/DCCT_Cpep/baseline.ssd01 Inode Number: 259045 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 704512 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Label -------------------------------------------------------------------------------- 4 ADULT Num 4 21 Adult >=18 (0=no/1=yes) 60 AER Num 8 309 Albuminuri (mg/24hr, Form 23b) 5 AGE Num 4 25 Age (From Master) at entry 58 BCVAL2 Num 5 296 T2-Glucose (ser, pre) mg/dl 59 BCVAL5 Num 8 301 Stimulated C-Peptide(pmol/ml, Form 023A) 68 BCVAL25A Num 8 358 T25-BGP1 mg/dl 69 BCVAL26A Num 8 366 T26-BGP2 mg/dl 70 BCVAL27A Num 8 374 T27-BGP3 mg/dl 71 BCVAL28A Num 8 382 T28-BGP4 mg/dl 72 BCVAL29A Num 8 390 T29-BGP5 mg/dl 73 BCVAL30A Num 8 398 T30-BGP6 mg/dl 74 BCVAL31A Num 8 406 T31-BGP7 mg/dl 57 BDHRATE Num 5 291 ECG Heart Rate 24 BMI Num 8 118 Body Mass Index (kg/m2) 56 CALORIES Num 8 283 Calories (kcal) 63 CHOL Num 5 330 Cholesterol (serum,mg/dl, Form 023C) 62 CREAT Num 5 325 Creatinine Clearance (ml/mn, Form 23b) 36 DRINKS Num 4 188 Current Drinker (0=no,1=yes) 6 DURATION Num 5 29 Total Months Duration of IDDM at entry 55 EDUCAT Num 8 275 Mean Education (Years) - Form 013 37 EXERCISE Num 4 192 Level of Exericse (1=Strenuous...4=Mild) 7 F002DATE Char 6 34 Date Form 002 Completed 21 FAMEYE Num 4 98 Fam Hist Eye Dz due to Diabetes (0/1) 19 FAMHT Num 4 90 Family History of HT (0=no/1=yes) 17 FAMIDDM Num 4 82 Family History of IDDM (0=no/1=yes) 20 FAMMI Num 4 94 Family History of MI (0=no/1=yes) 18 FAMNIDDM Num 4 86 Family History of NIDDM (0=no/1=yes) 54 FULLIQ Num 5 270 Full Scale IQ The SAS System 2 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label -------------------------------------------------------------------------------- 75 GFRX00 Num 8 414 Glomerular Filtration Rate (ml/min) 1 GROUP Char 13 0 Randomization Group 79 HBA00 Num 8 446 Hemoglobin A1c at Baseline (Form 066) 80 HBAEL Num 8 454 Hemoglobin A1c at Eligibility 65 HDL Num 5 340 HDL Cholesterol (serum,mg/dl, Form 023C) 14 HOLLSCOR Num 8 66 Hollingshead(2 Factor)Social Class score 31 INSULIN Num 8 164 Total Insulin Dosage Units/Weight (kg) 22 IW Num 8 102 Gender Specific Ideal Body Weight 66 LDL Num 5 345 LDL Cholesterol (serum,mg/dl, Form 023C) 10 MARRIED Num 4 50 Marital Status (0=NOT Married,1=Married) 81 MASK_PAT Num 8 462 Patient ID Number 28 MBP Num 8 146 Mean Arterial Pressure 51 NEURODEF Num 4 250 Presence of Clinical Neuropathy 13 OBC9 Num 4 62 Needed IV Glucose 41 OBC8A Num 4 208 Lost Consciousness without Seizure 42 OBC8B Num 4 212 Lost Consciousness with Seizure 29 OBDBP1 Num 5 154 Diastolic BP (mm Hg, Form 002) 39 OBDKAHSP Num 4 200 Hospitalizations for DKA in Past Year 32 OBGU7 Num 4 172 Kidney or Bladder Inf. w/ Antibiotics 27 OBHEIGHT Num 8 138 Height (cm) at Baseline 40 OBHYPHSP Num 4 204 Hospitalizations for Hypog. in Past Yr 11 OBMARRY Num 4 54 Marital Status 43 OBNEUR2 Num 4 216 Seizures 8 OBONSET Num 5 40 Month and Year of IDDM Onset 16 OBPATED Num 4 78 Patient's Education 15 OBPATJOB Num 4 74 Patient's Occupation 44 OBPSYCH5 Num 4 220 Suicide Attempt 45 OBPSYCH7 Num 4 224 Psychiatric Treatment 38 OBRACE Num 4 196 Race 30 OBSBP1 Num 5 159 Systolic BP (mm Hg, Form 002) 25 OBSEX Num 4 126 Sex 34 OBSMOK1 Num 4 180 Ever Smoked Cigarettes 35 OBSMOK2 Num 4 184 Now Smokes Cigarettes 26 OBWEIGHT Num 8 130 Weight (kg) at Baseline 47 OHF3LE Num 5 233 Visual Acuity Score-Left Eye (Form 008) 46 OHF3RE Num 5 228 Visual Acuity Score-Right Eye (Form 008) 2 PHASE Num 4 13 Phase Randomized (2,3) 23 PIDW Num 8 110 % Ideal Body Weight (OBWEIGHT/IW)*100 9 PPDUR Num 5 45 Post-Pubescent Duration (mos) 12 PRIORHYP Num 4 58 Past Hx of Severe Hypo(0=0,1=1-2,2= >=3) 49 RET5 Num 4 242 Retinopathy Level -Baseline (DCCT Scale) 3 RETBASE Char 4 17 Retinopathy at Baseline (PRIM,SCND) 48 RETPAT Num 4 238 Level of Retinopathy (1 - 4) 50 RETPAT00 Num 4 246 Retinopathy Severity Level 52 RRV00 Num 8 254 ANS - RR Variation (x 1000) 61 SCR Num 8 317 Serum Creatinine (mg/dl, Form 23b) 33 SMOKES Num 4 176 Smoking Status(1=never,2=ever,3=current) 78 TOTQOL Num 8 438 Quality of Life Total Score 64 TRG Num 5 335 Triglycerides (serum,mg/dl, Form 023C) 77 TSCDEP Num 8 430 T-Score Depression 76 TSCGSI Num 8 422 T-Score Global Severity Index 53 VALS00 Num 8 262 ANS - Valsalva Ratio 67 WPMEAN Num 8 350 Within-Profile Mean Blood Glucose(mg/dl) The SAS System 3 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.MS2EXPRT Observations: 1441 Member Type: DATA Variables: 284 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 928 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 65536 Number of Data Set Pages: 22 File Format: 607 First Data Page: 1 Max Obs per Page: 70 Obs in First Data Page: 32 File Name: /home/squid/will/DCCT_Cpep/ms2exprt.ssd01 Inode Number: 259598 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 1449984 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Label ---------------------------------------------------------------------------- 5 ADULT Num 3 23 Adult (Age>=18 yrs) at Base (0=No,1=Yes) 33 AERCAT Num 3 157 AER in 4 levels 4 AGE Num 3 20 Age (years) at Baseline 78 ANYMA00 Num 3 297 Any Ma (either eye) Baseline 79 ANYMA02 Num 3 300 Any Ma (either eye) QV 02 80 ANYMA04 Num 3 303 Any Ma (either eye) QV 04 81 ANYMA06 Num 3 306 Any Ma (either eye) QV 06 82 ANYMA08 Num 3 309 Any Ma (either eye) QV 08 83 ANYMA10 Num 3 312 Any Ma (either eye) QV 10 84 ANYMA12 Num 3 315 Any Ma (either eye) QV 12 85 ANYMA14 Num 3 318 Any Ma (either eye) QV 14 86 ANYMA16 Num 3 321 Any Ma (either eye) QV 16 87 ANYMA18 Num 3 324 Any Ma (either eye) QV 18 88 ANYMA20 Num 3 327 Any Ma (either eye) QV 20 89 ANYMA22 Num 3 330 Any Ma (either eye) QV 22 90 ANYMA24 Num 3 333 Any Ma (either eye) QV 24 91 ANYMA26 Num 3 336 Any Ma (either eye) QV 26 92 ANYMA28 Num 3 339 Any Ma (either eye) QV 28 93 ANYMA30 Num 3 342 Any Ma (either eye) QV 30 94 ANYMA32 Num 3 345 Any Ma (either eye) QV 32 95 ANYMA34 Num 3 348 Any Ma (either eye) QV 34 96 ANYMA36 Num 3 351 Any Ma (either eye) QV 36 23 BMI Num 8 117 Body Mass Index (kg/m2) 18 CHOL Num 8 77 Cholesterol (mg/dl) at Baseline 35 CLR0 Num 8 163 Stand. Clearance (ml/mn/1.73m2) at Base 205 CSMEFLG Num 3 683 CSME (0=No,1=Yes) 250 CSMEVIS Num 3 818 QV Number of CSME 27 DBP Num 3 139 Diastolic BP (mm Hg, Form 002) The SAS System 4 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label ---------------------------------------------------------------------------- 8 DUR5 Num 3 32 Duration >= 5 years at Base (0=No,1=Yes) 7 DURATION Num 3 29 Duration of IDDM (months) at Baseline 227 E3O6FLG Num 3 749 3-Step Change from 18 mos. (ETDRS) 272 E3O6VIS Num 3 884 QV of 3-Step Change from 18 mos (ETDRS) 228 E3P6FLG Num 3 752 Pers. 3-Step Change from 18 mos (ETDRS) 273 E3P6VIS Num 3 887 QV of Pers 3-Stp Ch from 18 mos (ETDRS) 206 EDELGFLG Num 3 686 Macular Edema(ETDRS Entry) (0=No,1=Yes) 251 EDELGVIS Num 3 821 QV of Macular Edema (ETDRS Entry Defn.) 116 EDEMA00 Num 3 411 CSME (either eye) Baseline 117 EDEMA02 Num 3 414 CSME (either eye) QV 02 118 EDEMA04 Num 3 417 CSME (either eye) QV 04 119 EDEMA06 Num 3 420 CSME (either eye) QV 06 120 EDEMA08 Num 3 423 CSME (either eye) QV 08 121 EDEMA10 Num 3 426 CSME (either eye) QV 10 122 EDEMA12 Num 3 429 CSME (either eye) QV 12 123 EDEMA14 Num 3 432 CSME (either eye) QV 14 124 EDEMA16 Num 3 435 CSME (either eye) QV 16 125 EDEMA18 Num 3 438 CSME (either eye) QV 18 126 EDEMA20 Num 3 441 CSME (either eye) QV 20 127 EDEMA22 Num 3 444 CSME (either eye) QV 22 128 EDEMA24 Num 3 447 CSME (either eye) QV 24 129 EDEMA26 Num 3 450 CSME (either eye) QV 26 130 EDEMA28 Num 3 453 CSME (either eye) QV 28 131 EDEMA30 Num 3 456 CSME (either eye) QV 30 132 EDEMA32 Num 3 459 CSME (either eye) QV 32 133 EDEMA34 Num 3 462 CSME (either eye) QV 34 134 EDEMA36 Num 3 465 CSME (either eye) QV 36 201 ET53PFLG Num 3 671 Pers. SNPDR (ETDRS 53/<53) (0=No,1=Yes) 246 ET53PVIS Num 3 806 QV of Persistent SNPDR (ETDRS 53/<53) 232 ETD3OFLG Num 3 764 3-Step Change using ETDRS (0=No,1=Yes) 277 ETD3OVIS Num 3 899 QV of 3-Step Change using ETDRS 233 ETD3PFLG Num 3 767 Pers. 3-Step Change - ETDRS (0=No,1=Yes) 278 ETD3PVIS Num 3 902 QV of Pers. 3-Step Change using ETDRS 200 ETD53FLG Num 3 668 Severe NPDR (ETDRS 53/<53) (0=No,1=Yes) 245 ETD53VIS Num 3 803 QV of Severe NPDR (ETDRS 53/<53) 202 ETD61FLG Num 3 674 ETDRS Level 61/<61 (0=No,1=Yes) 247 ETD61VIS Num 3 809 QV of ETDRS Level 61/<61 135 ETDPAT00 Num 3 468 ETDRS Scale (patient) Baseline 136 ETDPAT02 Num 3 471 ETDRS Scale (patient) QV 02 137 ETDPAT04 Num 3 474 ETDRS Scale (patient) QV 04 138 ETDPAT06 Num 3 477 ETDRS Scale (patient) QV 06 139 ETDPAT08 Num 3 480 ETDRS Scale (patient) QV 08 140 ETDPAT10 Num 3 483 ETDRS Scale (patient) QV 10 141 ETDPAT12 Num 3 486 ETDRS Scale (patient) QV 12 142 ETDPAT14 Num 3 489 ETDRS Scale (patient) QV 14 143 ETDPAT16 Num 3 492 ETDRS Scale (patient) QV 16 144 ETDPAT18 Num 3 495 ETDRS Scale (patient) QV 18 145 ETDPAT20 Num 3 498 ETDRS Scale (patient) QV 20 146 ETDPAT22 Num 3 501 ETDRS Scale (patient) QV 22 147 ETDPAT24 Num 3 504 ETDRS Scale (patient) QV 24 148 ETDPAT26 Num 3 507 ETDRS Scale (patient) QV 26 149 ETDPAT28 Num 3 510 ETDRS Scale (patient) QV 28 150 ETDPAT30 Num 3 513 ETDRS Scale (patient) QV 30 The SAS System 5 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label ---------------------------------------------------------------------------- 151 ETDPAT32 Num 3 516 ETDRS Scale (patient) QV 32 152 ETDPAT34 Num 3 519 ETDRS Scale (patient) QV 34 153 ETDPAT36 Num 3 522 ETDRS Scale (patient) QV 36 154 ETDPAT99 Num 3 525 ETDRS Scale (patient) Close Out 38 ETDPATB Num 3 177 Retinopathy at Base (ETDRS Levels, >8=8) 222 EY4E3FLG Num 3 734 3-Step Change in 1st 12 mos.(ETDRS) 267 EY4E3VIS Num 3 869 QV of 3-Stp Change in 1st 12 mos (ETDRS) 220 EY4S3FLG Num 3 728 3-Step Change in First 12 mos. 265 EY4S3VIS Num 3 863 QV of 3-Step Change in First 12 mos. 221 EY4SPFLG Num 3 731 Pers. 3-Step Change in First 12 mos. 266 EY4SPVIS Num 3 866 QV of Pers. 3-Step Ch in First 12 mos. 229 EYSEP4F Num 3 755 SE and/or IRMA in First 12 mos. 274 EYSEP4V Num 3 890 QV of SE and/or IRMA in First 12 mos. 6 FEMALE Num 3 26 Gender (0=Male,1=Female) 1 GROUP Char 13 0 Treatment Group (Exp,Std) 193 HBA00 Num 8 642 HbA1c (baseline) 16 HBADF Num 8 61 HbA1c: Eligibility-Baseline 15 HBAEL Num 8 53 Hemoglobin A1c (%) at Eligibility 20 HDL Num 8 93 HDL Cholesterol (serum,mg/dl, Form 023C) 34 HYPF0 Num 3 160 Hyperfiltration at Baseline (0=No,1=Yes) 24 INSULIN Num 8 125 Total Insulin Dosage Units/Weight (kg) 198 L6THRFLG Num 3 662 DCCT Threshold from 18 mos. Flag 243 L6THRVIS Num 3 797 QV of DCCT Thresh from 18 mos. 196 L8S3PFLG Num 3 656 Pers 3-Step Ch At of After 24 mos. Flag 241 L8S3PVIS Num 3 791 QV of P 3-Stp Ch At or After 24 mos. 204 LASFFLG Num 3 680 Focal Laser in Either Eye (0=No,1=Yes) 249 LASFVIS Num 3 815 QV of Focal Laser in Either Eye 203 LASSFLG Num 3 677 Scatter Laser in Either Eye (0=No,1=Yes) 248 LASSVIS Num 3 812 QV of Scatter Laser in Either Eye 36 LASTVIS Num 3 171 QV Most Recent (if > 00) 21 LDL Num 8 101 LDL Cholesterol (serum,mg/dl, Form 023C) 208 MA1FLG Num 3 692 >=1 Microaneurysm (0=No,1=Yes) 209 MA1PFLG Num 3 695 Pers. >=1 Microaneurysm (0=No,1=Yes) 254 MA1PVIS Num 3 830 QV of Persistent >=1 Microaneurysm 253 MA1VIS Num 3 827 QV of >=1 Microaneurysm 210 MA3FLG Num 3 698 >=3 Microaneurysms (0=No,1=Yes) 211 MA3PFLG Num 3 701 Pers. >=3 Microaneurysm (0=No,1=Yes) 256 MA3PVIS Num 3 836 QV of Persistent >=3 Microaneurysm 255 MA3VIS Num 3 833 QV of >=3 Microaneurysms 97 MAPAT00 Num 3 354 Total Ma (Right + Left) Baseline 98 MAPAT02 Num 3 357 Total Ma (Right + Left) QV 02 99 MAPAT04 Num 3 360 Total Ma (Right + Left) QV 04 100 MAPAT06 Num 3 363 Total Ma (Right + Left) QV 06 101 MAPAT08 Num 3 366 Total Ma (Right + Left) QV 08 102 MAPAT10 Num 3 369 Total Ma (Right + Left) QV 10 103 MAPAT12 Num 3 372 Total Ma (Right + Left) QV 12 104 MAPAT14 Num 3 375 Total Ma (Right + Left) QV 14 105 MAPAT16 Num 3 378 Total Ma (Right + Left) QV 16 106 MAPAT18 Num 3 381 Total Ma (Right + Left) QV 18 107 MAPAT20 Num 3 384 Total Ma (Right + Left) QV 20 108 MAPAT22 Num 3 387 Total Ma (Right + Left) QV 22 109 MAPAT24 Num 3 390 Total Ma (Right + Left) QV 24 110 MAPAT26 Num 3 393 Total Ma (Right + Left) QV 26 The SAS System 6 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label ---------------------------------------------------------------------------- 111 MAPAT28 Num 3 396 Total Ma (Right + Left) QV 28 112 MAPAT30 Num 3 399 Total Ma (Right + Left) QV 30 113 MAPAT32 Num 3 402 Total Ma (Right + Left) QV 32 114 MAPAT34 Num 3 405 Total Ma (Right + Left) QV 34 115 MAPAT36 Num 3 408 Total Ma (Right + Left) QV 36 284 MASK_PAT Num 8 920 Patient ID number 17 MBP Num 8 69 Mean Arterial Pressure 237 NEOVFLG Num 3 779 New Vessels on Disc or Elsewhere 282 NEOVVIS Num 3 914 QV of New Vessels on Disc or Elsewhere 26 NEUR Num 3 136 Clinical Neuropathy (0=no,1=yes 236 NVBFLG Num 3 776 New Vessels on Disc and Elsewhere 281 NVBVIS Num 3 911 QV of New Vessels on Disc and Elsewhere 234 NVDFLG Num 3 770 New Vessels on Disc (0=No,1=Yes) 155 NVDPAT00 Num 3 528 NVD (either eye) Baseline 156 NVDPAT02 Num 3 531 NVD (either eye) QV 02 157 NVDPAT04 Num 3 534 NVD (either eye) QV 04 158 NVDPAT06 Num 3 537 NVD (either eye) QV 06 159 NVDPAT08 Num 3 540 NVD (either eye) QV 08 160 NVDPAT10 Num 3 543 NVD (either eye) QV 10 161 NVDPAT12 Num 3 546 NVD (either eye) QV 12 162 NVDPAT14 Num 3 549 NVD (either eye) QV 14 163 NVDPAT16 Num 3 552 NVD (either eye) QV 16 164 NVDPAT18 Num 3 555 NVD (either eye) QV 18 165 NVDPAT20 Num 3 558 NVD (either eye) QV 20 166 NVDPAT22 Num 3 561 NVD (either eye) QV 22 167 NVDPAT24 Num 3 564 NVD (either eye) QV 24 168 NVDPAT26 Num 3 567 NVD (either eye) QV 26 169 NVDPAT28 Num 3 570 NVD (either eye) QV 28 170 NVDPAT30 Num 3 573 NVD (either eye) QV 30 171 NVDPAT32 Num 3 576 NVD (either eye) QV 32 172 NVDPAT34 Num 3 579 NVD (either eye) QV 34 173 NVDPAT36 Num 3 582 NVD (either eye) QV 36 279 NVDVIS Num 3 905 QV of New Vessels on Disc 235 NVEFLG Num 3 773 New Vessels Elsewhere (0=No,1=Yes) 174 NVEPAT00 Num 3 585 NVE (either eye) Baseline 175 NVEPAT02 Num 3 588 NVE (either eye) QV 02 176 NVEPAT04 Num 3 591 NVE (either eye) QV 04 177 NVEPAT06 Num 3 594 NVE (either eye) QV 06 178 NVEPAT08 Num 3 597 NVE (either eye) QV 08 179 NVEPAT10 Num 3 600 NVE (either eye) QV 10 180 NVEPAT12 Num 3 603 NVE (either eye) QV 12 181 NVEPAT14 Num 3 606 NVE (either eye) QV 14 182 NVEPAT16 Num 3 609 NVE (either eye) QV 16 183 NVEPAT18 Num 3 612 NVE (either eye) QV 18 184 NVEPAT20 Num 3 615 NVE (either eye) QV 20 185 NVEPAT22 Num 3 618 NVE (either eye) QV 22 186 NVEPAT24 Num 3 621 NVE (either eye) QV 24 187 NVEPAT26 Num 3 624 NVE (either eye) QV 26 188 NVEPAT28 Num 3 627 NVE (either eye) QV 28 189 NVEPAT30 Num 3 630 NVE (either eye) QV 30 190 NVEPAT32 Num 3 633 NVE (either eye) QV 32 191 NVEPAT34 Num 3 636 NVE (either eye) QV 34 192 NVEPAT36 Num 3 639 NVE (either eye) QV 36 The SAS System 7 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label ---------------------------------------------------------------------------- 280 NVEVIS Num 3 908 QV of New Vessels Elsewhere 3 PHASE Num 3 17 Phase Randomized (2,3) 22 PIDW Num 8 109 % Ideal Body Weight (OBWEIGHT/IW)*100 25 PIDW120 Num 3 133 % of Ideal Body Weight >=120(0=no/1=yes) 9 PPDUR Num 3 35 Post-Pubescent Duration (mos) 10 PPDUR5 Num 3 38 Post-Pub Dur>=5 yrs at Base (0=No,1=Yes) 13 PUREPRIM Num 3 47 Free of Retinopathy at Base (0=No,1=Yes) 29 QCHOL Num 3 145 Quartiles: Cholesterol - Baseline 14 QHBAEL Num 3 50 Quartiles: HbA1c at Eligibility 30 QHDL Num 3 148 Quartiles: HDL-Cholesterol - Baseline 31 QLDL Num 3 151 Quartiles: LDL-Cholesterol - Baseline 32 QTRG Num 3 154 Quartiles: Triglycerides - Baseline 219 RE53PFLG Num 3 725 Recovery from Pers. SNPDR (53/<53) 264 RE53PVIS Num 3 860 QV of Recovery from Pers. SNPDR (53/<53) 216 REE3OFLG Num 3 716 Recovery from 3-stp change (ETDRS) 261 REE3OVIS Num 3 851 QV of Recovery from 3-stp change (ETDRS) 217 REE3PFLG Num 3 719 Recovery from Pers 3-stp change (ETDRS) 262 REE3PVIS Num 3 854 QV of Recov from Pers 3-stp chng (ETDRS) 218 REE53FLG Num 3 722 Recovery from SNPDR (ETDRS 53/<53) 263 REE53VIS Num 3 857 QV of Recovery from SNPDR (53/<53) 212 REM1PFLG Num 3 704 Recovery from Pers >=1 m.a. (0=No,1=Yes) 257 REM1PVIS Num 3 839 QV of Recovery from Pers >= 1 m.a. 213 REM3PFLG Num 3 707 Recovery from >= 3 m.a. (0=No,1=Yes) 258 REM3PVIS Num 3 842 QV of Recovery from Pers >= 3 m.a. 214 RES3OFLG Num 3 710 Recovery from 3-stp change (0=No,1=Yes) 259 RES3OVIS Num 3 845 QV of Recovery from 3-stp change 215 RES3PFLG Num 3 713 Recovery from S. 3-stp ch (0=No,1=Yes) 260 RES3PVIS Num 3 848 QV of Recovery from Sust. 3-stp change 199 RET50FLG Num 3 665 DCCT Level 50/<50 (0=No,1=Yes) 244 RET50VIS Num 3 800 QV of DCCT Level 50/<50 2 RETBASE Char 4 13 Baseline Retinopathy Strata (Prim,Sec) 207 RETI3FLG Num 3 689 3-Stp Improvement from Base (0=No,1=Yes) 252 RETI3VIS Num 3 824 QV of 3-Stp Improvement from Base 12 RETPAT Num 3 44 Level of Retinopathy (1 - 4) 39 RETPAT00 Num 3 180 Baseline Retinopathy (DCCT Scale) 40 RETPAT02 Num 3 183 QV 02 Retinopathy (DCCT Scale) 41 RETPAT04 Num 3 186 QV 04 Retinopathy (DCCT Scale) 42 RETPAT06 Num 3 189 QV 06 Retinopathy (DCCT Scale) 43 RETPAT08 Num 3 192 QV 08 Retinopathy (DCCT Scale) 44 RETPAT10 Num 3 195 QV 10 Retinopathy (DCCT Scale) 45 RETPAT12 Num 3 198 QV 12 Retinopathy (DCCT Scale) 46 RETPAT14 Num 3 201 QV 14 Retinopathy (DCCT Scale) 47 RETPAT16 Num 3 204 QV 16 Retinopathy (DCCT Scale) 48 RETPAT18 Num 3 207 QV 18 Retinopathy (DCCT Scale) 49 RETPAT20 Num 3 210 QV 20 Retinopathy (DCCT Scale) 50 RETPAT22 Num 3 213 QV 22 Retinopathy (DCCT Scale) 51 RETPAT24 Num 3 216 QV 24 Retinopathy (DCCT Scale) 52 RETPAT26 Num 3 219 QV 26 Retinopathy (DCCT Scale) 53 RETPAT28 Num 3 222 QV 28 Retinopathy (DCCT Scale) 54 RETPAT30 Num 3 225 QV 30 Retinopathy (DCCT Scale) 55 RETPAT32 Num 3 228 QV 32 Retinopathy (DCCT Scale) 56 RETPAT34 Num 3 231 QV 34 Retinopathy (DCCT Scale) 57 RETPAT36 Num 3 234 QV 36 Retinopathy (DCCT Scale) The SAS System 8 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Label ---------------------------------------------------------------------------- 58 RETPAT99 Num 3 237 Close Out Retinopathy (DCCT Scale) 37 RETPATB Num 3 174 Retinopathy at Base (DCCT Levels, 8+9=8) 231 REYE3FLG Num 3 761 Recovery from Early 3-stp change (ETDRS) 276 REYE3VIS Num 3 896 QV of Recov from Early 3-stp ch (ETDRS) 223 REYS3FLG Num 3 737 Recovery from Early 3-stp change 268 REYS3VIS Num 3 872 QV of Recovery from Early 3-stp ch 230 REYSEFLG Num 3 758 Recovery from SE and/or IRMA 275 REYSEVIS Num 3 893 QV of Recovery from SE and/or IRMA 224 REYSPFLG Num 3 740 Recovery from Early Sust 3-stp change 269 REYSPVIS Num 3 875 QV of Recovery from Early Sust 3-stp ch 225 S3O6FLG Num 3 743 3-Step Change from 18 mos. (0=No,1=Yes) 270 S3O6VIS Num 3 878 QV of 3-Step Change from 18 mos. 226 S3P6FLG Num 3 746 Pers. 3-Step Change from 18 mos. 271 S3P6VIS Num 3 881 QV of P3-Step Change from 18 mos. 28 SBP Num 3 142 Systolic BP (mm Hg, Form 002) 11 SMOKES Num 3 41 Smoking Status(1=never,2=ever,3=current) 59 STEP300 Num 3 240 3 Step Change from Baseline (Baseline) 60 STEP302 Num 3 243 3 Step Change from Baseline (QV 02) 61 STEP304 Num 3 246 3 Step Change from Baseline (QV 04) 62 STEP306 Num 3 249 3 Step Change from Baseline (QV 06) 63 STEP308 Num 3 252 3 Step Change from Baseline (QV 08) 64 STEP310 Num 3 255 3 Step Change from Baseline (QV 10) 65 STEP312 Num 3 258 3 Step Change from Baseline (QV 12) 66 STEP314 Num 3 261 3 Step Change from Baseline (QV 14) 67 STEP316 Num 3 264 3 Step Change from Baseline (QV 16) 68 STEP318 Num 3 267 3 Step Change from Baseline (QV 18) 69 STEP320 Num 3 270 3 Step Change from Baseline (QV 20) 70 STEP322 Num 3 273 3 Step Change from Baseline (QV 22) 71 STEP324 Num 3 276 3 Step Change from Baseline (QV 24) 72 STEP326 Num 3 279 3 Step Change from Baseline (QV 26) 73 STEP328 Num 3 282 3 Step Change from Baseline (QV 28) 74 STEP330 Num 3 285 3 Step Change from Baseline (QV 30) 75 STEP332 Num 3 288 3 Step Change from Baseline (QV 32) 76 STEP334 Num 3 291 3 Step Change from Baseline (QV 34) 77 STEP336 Num 3 294 3 Step Change from Baseline (QV 36) 194 STP3OFLG Num 3 650 3 Step Change (0=No,1=Yes) 239 STP3OVIS Num 3 785 QV Number for first 3-step change 195 STP3PFLG Num 3 653 P3 Step Change (0=No,1=Yes) 240 STP3PVIS Num 3 788 QV Number of Pers. 3-step change 197 THRESFLG Num 3 659 DCCT Threshold (0=No,1=Yes) 242 THRESVIS Num 3 794 QV Number for DCCT Threshold 19 TRG Num 8 85 Triglycerides (serum,mg/dl, Form 023C) 238 VISACFLG Num 3 782 Decline in Visual Acuity (0/1) 283 VISACVIS Num 3 917 QV of Decline in Visual Acuity The SAS System 9 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.MS3EXPRT Observations: 1441 Member Type: DATA Variables: 234 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 1463 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 65536 Number of Data Set Pages: 34 File Format: 607 First Data Page: 1 Max Obs per Page: 44 Obs in First Data Page: 24 File Name: /home/squid/will/DCCT_Cpep/ms3exprt.ssd01 Inode Number: 259639 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 2236416 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 6 ADULT Num 3 26 Adult (Age>=18 yrs) at Base (0=No,1=Yes) 37 AER00 Num 8 164 Albumin Excretion Rate (mg/24hr) at Base 38 AER04 Num 8 172 Albumin Excretion Rate (mg/24hr) at Yr 1 39 AER08 Num 8 180 Albumin Excretion Rate (mg/24hr) at Yr 2 40 AER12 Num 8 188 Albumin Excretion Rate (mg/24hr) at Yr 3 41 AER16 Num 8 196 Albumin Excretion Rate (mg/24hr) at Yr 4 42 AER20 Num 8 204 Albumin Excretion Rate (mg/24hr) at Yr 5 43 AER24 Num 8 212 Albumin Excretion Rate (mg/24hr) at Yr 6 44 AER28 Num 8 220 Albumin Excretion Rate (mg/24hr) at Yr 7 45 AER32 Num 8 228 Albumin Excretion Rate (mg/24hr) at Yr 8 46 AER36 Num 8 236 Albumin Excretion Rate (mg/24hr) at Yr 9 23 AERBS15 Num 3 97 AER at Baseline (0,1)=(<15,>=15) 24 AERBS40 Num 3 100 AER at Baseline (0,1)=(<40,>=40) 5 AGE Num 3 23 Age (years) at Baseline 216 BMI Num 8 1326 Body Mass Index (kg/m2) 26 CHOL Num 8 111 Cholesterol (mg/dl) at Baseline 187 CL70PFLG Num 3 1219 Sustained Impaired GFR (0=No,1=Yes) 208 CL70PVIS Num 3 1282 QV of Sustained Impaired GFR 57 CLR00 Num 8 324 Stand. Clearance (ml/mn/1.73m2) at Base 58 CLR04 Num 8 332 Stand. Clearance (ml/mn/1.73m2) at Yr 1 59 CLR08 Num 8 340 Stand. Clearance (ml/mn/1.73m2) at Yr 2 60 CLR12 Num 8 348 Stand. Clearance (ml/mn/1.73m2) at Yr 3 61 CLR16 Num 8 356 Stand. Clearance (ml/mn/1.73m2) at Yr 4 62 CLR20 Num 8 364 Stand. Clearance (ml/mn/1.73m2) at Yr 5 63 CLR24 Num 8 372 Stand. Clearance (ml/mn/1.73m2) at Yr 6 64 CLR28 Num 8 380 Stand. Clearance (ml/mn/1.73m2) at Yr 7 65 CLR32 Num 8 388 Stand. Clearance (ml/mn/1.73m2) at Yr 8 66 CLR36 Num 8 396 Stand. Clearance (ml/mn/1.73m2) at Yr 9 The SAS System 10 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 186 CLR70FLG Num 3 1216 First Occur of Clr<70 (0=No,1=Yes) 207 CLR70VIS Num 3 1279 QV of First Occurence of Clr<70 87 CLRB00 Num 8 564 Std. Clr. by BSA0 (ml/mn/1.73m2) at Base 88 CLRB04 Num 8 572 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 1 89 CLRB08 Num 8 580 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 2 90 CLRB12 Num 8 588 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 3 91 CLRB16 Num 8 596 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 4 92 CLRB20 Num 8 604 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 5 93 CLRB24 Num 8 612 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 6 94 CLRB28 Num 8 620 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 7 95 CLRB32 Num 8 628 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 8 96 CLRB36 Num 8 636 Std. Clr. by BSA0 (ml/mn/1.73m2) at Yr 9 214 CLRB99 Num 8 1310 Std Clr by BSA0 (ml/mn/1.73m2) at Close 138 DBP00 Num 8 972 Diastolic Blood Pressure (mm Hg) at Base 139 DBP04 Num 8 980 Diastolic Blood Pressure (mm Hg) at Yr 1 140 DBP08 Num 8 988 Diastolic Blood Pressure (mm Hg) at Yr 2 141 DBP12 Num 8 996 Diastolic Blood Pressure (mm Hg) at Yr 3 142 DBP16 Num 8 1004 Diastolic Blood Pressure (mm Hg) at Yr 4 143 DBP20 Num 8 1012 Diastolic Blood Pressure (mm Hg) at Yr 5 144 DBP24 Num 8 1020 Diastolic Blood Pressure (mm Hg) at Yr 6 145 DBP28 Num 8 1028 Diastolic Blood Pressure (mm Hg) at Yr 7 146 DBP32 Num 8 1036 Diastolic Blood Pressure (mm Hg) at Yr 8 147 DBP36 Num 8 1044 Diastolic Blood Pressure (mm Hg) at Yr 9 11 DURATION Num 3 51 Duration of IDDM (months) at Baseline 20 FAMDNEPH Num 3 78 Family Hist of Diabet Neph (0=No,1=Yes) 18 FAMHT Num 3 72 Family Hist of Hypertension (0=No,1=Yes) 17 FAMIDDM Num 3 69 Family Hist of IDDM (0=No,1=Yes) 19 FAMNEPH Num 3 75 Family Hist of Nephropathy (0=No,1=Yes) 7 FEMALE Num 3 29 Gender (0=Male,1=Female) 158 GFRCLYR Num 3 1132 Study Year (est.) CloseOut GFR 97 GFRX00 Num 8 644 GFR Mean at Baseline 98 GFRX04 Num 8 652 GFR Mean at Year 1 99 GFRX08 Num 8 660 GFR Mean at Year 2 100 GFRX12 Num 8 668 GFR Mean at Year 3 101 GFRX16 Num 8 676 GFR Mean at Year 4 102 GFRX20 Num 8 684 GFR Mean at Year 5 103 GFRX24 Num 8 692 GFR Mean at Year 6 104 GFRX28 Num 8 700 GFR Mean at Year 7 105 GFRX32 Num 8 708 GFR Mean at Year 8 106 GFRX36 Num 8 716 GFR Mean at Year 9 107 GFRX99 Num 8 724 GFR Mean at Close-Out 118 GFRXB00 Num 8 812 GFR Mean Adjusted for BSA0 at Baseline 119 GFRXB04 Num 8 820 GFR Mean Adjusted for BSA0 at Year 1 120 GFRXB08 Num 8 828 GFR Mean Adjusted for BSA0 at Year 2 121 GFRXB12 Num 8 836 GFR Mean Adjusted for BSA0 at Year 3 122 GFRXB16 Num 8 844 GFR Mean Adjusted for BSA0 at Year 4 123 GFRXB20 Num 8 852 GFR Mean Adjusted for BSA0 at Year 5 124 GFRXB24 Num 8 860 GFR Mean Adjusted for BSA0 at Year 6 125 GFRXB28 Num 8 868 GFR Mean Adjusted for BSA0 at Year 7 126 GFRXB32 Num 8 876 GFR Mean Adjusted for BSA0 at Year 8 127 GFRXB36 Num 8 884 GFR Mean Adjusted for BSA0 at Year 9 215 GFRXB99 Num 8 1318 GFR Mean Adjusted for BSA0 at Close-Out 108 GFRXU00 Num 8 732 Unadjusted GFR Mean at Baseline The SAS System 11 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 109 GFRXU04 Num 8 740 Unadjusted GFR Mean at Year 1 110 GFRXU08 Num 8 748 Unadjusted GFR Mean at Year 2 111 GFRXU12 Num 8 756 Unadjusted GFR Mean at Year 3 112 GFRXU16 Num 8 764 Unadjusted GFR Mean at Year 4 113 GFRXU20 Num 8 772 Unadjusted GFR Mean at Year 5 114 GFRXU24 Num 8 780 Unadjusted GFR Mean at Year 6 115 GFRXU28 Num 8 788 Unadjusted GFR Mean at Year 7 116 GFRXU32 Num 8 796 Unadjusted GFR Mean at Year 8 117 GFRXU36 Num 8 804 Unadjusted GFR Mean at Year 9 212 GFRXU99 Num 8 1294 Unadjusted GFR Mean at Close-Out 1 GROUP Char 13 0 Treatment Group (Exp,Std) 217 HBA00 Num 8 1334 Hemoglobin A1c at Baseline (Form 066) 21 HBAEL Num 8 81 Hemoglobin A1c (%) at Eligibility 27 HDL Num 8 119 HDL Cholesterol (mg/dl) at Baseline 8 HEIGHT Num 8 32 Height (cm) at Baseline 218 HISKIDIN Num 3 1342 Kidney or Bladder inf. w/ Antibiotics 170 HTFLG Num 3 1168 First Diag. of Hypertension (0=No,1=Yes) 191 HTVIS Num 3 1231 QV of First Diagnosis of Hypertension 159 HYPF00 Num 3 1135 Hyperfil.(Clr>=130) at Base (0=No,1=Yes) 160 HYPF04 Num 3 1138 Hyperfil.(Clr>=130) at Yr 1 (0=No,1=Yes) 161 HYPF08 Num 3 1141 Hyperfil.(Clr>=130) at Yr 2 (0=No,1=Yes) 162 HYPF12 Num 3 1144 Hyperfil.(Clr>=130) at Yr 3 (0=No,1=Yes) 163 HYPF16 Num 3 1147 Hyperfil.(Clr>=130) at Yr 4 (0=No,1=Yes) 164 HYPF20 Num 3 1150 Hyperfil.(Clr>=130) at Yr 5 (0=No,1=Yes) 165 HYPF24 Num 3 1153 Hyperfil.(Clr>=130) at Yr 6 (0=No,1=Yes) 169 HYPF25 Num 3 1165 Hyperfil.(Top 25%) at Base (0=No,1=Yes) 166 HYPF28 Num 3 1156 Hyperfil.(Clr>=130) at Yr 7 (0=No,1=Yes) 167 HYPF32 Num 3 1159 Hyperfil.(Clr>=130) at Yr 8 (0=No,1=Yes) 168 HYPF36 Num 3 1162 Hyperfil.(Clr>=130) at Yr 9 (0=No,1=Yes) 189 HYPI1FLG Num 3 1225 Hypf Improvement (CLR<130) (0=No,1=Yes) 210 HYPI1VIS Num 3 1288 QV of Hypf Improvement (CLR<130) 190 HYPI2FLG Num 3 1228 Hypf Improvement (CLR<143) (0=No,1=Yes) 211 HYPI2VIS Num 3 1291 QV of Hypf Improvement (CLR<143) 221 IBW00 Num 8 1351 5.1 Ideal Body Weight (%) at Baseline 222 IBW04 Num 8 1359 5.1 Ideal Body Weight (%) at Year 1 223 IBW08 Num 8 1367 5.1 Ideal Body Weight (%) at Year 2 224 IBW12 Num 8 1375 5.1 Ideal Body Weight (%) at Year 3 225 IBW16 Num 8 1383 5.1 Ideal Body Weight (%) at Year 4 226 IBW20 Num 8 1391 5.1 Ideal Body Weight (%) at Year 5 227 IBW24 Num 8 1399 5.1 Ideal Body Weight (%) at Year 6 228 IBW28 Num 8 1407 5.1 Ideal Body Weight (%) at Year 7 229 IBW32 Num 8 1415 5.1 Ideal Body Weight (%) at Year 8 230 IBW36 Num 8 1423 5.1 Ideal Body Weight (%) at Year 9 10 IBW120 Num 3 48 % of IB Weight>=120 at Base (0=No,1=Yes) 22 INSULIN Num 8 89 Total Insulin Dosage Units/Weight (kg) 47 LAER0 Num 8 244 Log(AER (mg/24hr)) at Base 4 LAST Num 3 20 Last Visit (Annual) 28 LDL Num 8 127 LDL Cholesterol (mg/dl) at Baseline 48 LEV04 Num 8 252 Nephropathy Class (1-6) - Level at Yr 1 49 LEV08 Num 8 260 Nephropathy Class (1-6) - Level at Yr 2 50 LEV12 Num 8 268 Nephropathy Class (1-6) - Level at Yr 3 51 LEV16 Num 8 276 Nephropathy Class (1-6) - Level at Yr 4 52 LEV20 Num 8 284 Nephropathy Class (1-6) - Level at Yr 5 The SAS System 12 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 53 LEV24 Num 8 292 Nephropathy Class (1-6) - Level at Yr 6 54 LEV28 Num 8 300 Nephropathy Class (1-6) - Level at Yr 7 55 LEV32 Num 8 308 Nephropathy Class (1-6) - Level at Yr 8 56 LEV36 Num 8 316 Nephropathy Class (1-6) - Level at Yr 9 234 MASK_PAT Num 8 1455 Patient ID number 148 MBP00 Num 8 1052 5.1 Mean Blood Pressure (mm Hg) at Baseline 149 MBP04 Num 8 1060 5.1 Mean Blood Pressure (mm Hg) at Year 1 150 MBP08 Num 8 1068 5.1 Mean Blood Pressure (mm Hg) at Year 2 151 MBP12 Num 8 1076 5.1 Mean Blood Pressure (mm Hg) at Year 3 152 MBP16 Num 8 1084 5.1 Mean Blood Pressure (mm Hg) at Year 4 153 MBP20 Num 8 1092 5.1 Mean Blood Pressure (mm Hg) at Year 5 154 MBP24 Num 8 1100 5.1 Mean Blood Pressure (mm Hg) at Year 6 155 MBP28 Num 8 1108 5.1 Mean Blood Pressure (mm Hg) at Year 7 156 MBP32 Num 8 1116 5.1 Mean Blood Pressure (mm Hg) at Year 8 157 MBP36 Num 8 1124 5.1 Mean Blood Pressure (mm Hg) at Year 9 185 N2P5FLG Num 3 1213 Neph Lvl 5 after Sus Lvl 2 (0=No,1=Yes) 206 N2P5VIS Num 3 1276 QV Time to Neph Lvl 5 after Sust Lvl 2 184 N2TO5FLG Num 3 1210 Neph Level 5 after Level 2 (0=No,1=Yes) 205 N2TO5VIS Num 3 1273 QV Time to Neph Level 5 after Level 2 171 NEPH1FLG Num 3 1171 First Occur. of Neph Levl 1 (0=No,1=Yes) 192 NEPH1VIS Num 3 1234 QV of First Occurence of Neph Lvl 1 172 NEPH2FLG Num 3 1174 First Occur. of Neph Levl 2 (0=No,1=Yes) 193 NEPH2VIS Num 3 1237 QV of First Occurence of Neph Lvl 2 173 NEPH3FLG Num 3 1177 First Occur. of Neph Levl 3 (0=No,1=Yes) 194 NEPH3VIS Num 3 1240 QV of First Occurence of Neph Lvl 3 174 NEPH4FLG Num 3 1180 First Occur. of Neph Levl 4 (0=No,1=Yes) 195 NEPH4VIS Num 3 1243 QV of First Occurence of Neph Lvl 4 175 NEPH5FLG Num 3 1183 First Occur. of Neph Levl 5 (0=No,1=Yes) 196 NEPH5VIS Num 3 1246 QV of First Occurence of Neph Lvl 5 176 NEPH6FLG Num 3 1186 Nephropathy Level 6 (0=No, 1=Yes) 197 NEPH6VIS Num 3 1249 QV of Nephropathy Level 6 181 NEPHIFLG Num 3 1201 First Occ. of Neph Improve (0=No,1=Yes) 202 NEPHIVIS Num 3 1264 QV of First Occur. of Neph Improvement 15 NEUR Num 3 63 Clinical Neuropathy Present (0=No,1=Yes) 183 NHTFLG Num 3 1207 Nephropathic Hypertension (0=No,1=Yes) 204 NHTVIS Num 3 1270 QV of Nephropathic Hypertension 177 NPH1BFLG Num 3 1189 Nephropathy Level 1b (0=No, 1=Yes) 198 NPH1BVIS Num 3 1252 QV of Nephropathy Level 1b 178 NPH2PFLG Num 3 1192 First Occ of Pers Nph Lvl 2 (0=No,1=Yes) 199 NPH2PVIS Num 3 1255 QV of First Occur. of Pers. Neph Level 2 233 NPH2WFLG Num 8 1447 1st Neph levl 2 exclu.preg. (0=No,1=Yes) 232 NPH2WVIS Num 8 1439 QV of 1st Neph levl 2 exclu.preg. 180 NPH3PFLG Num 3 1198 Persistent Neph Level 3 201 NPH3PVIS Num 3 1261 Persistent Neph Level 3 QV 179 NPH5PFLG Num 3 1195 First Occ of Pers Nph Lvl 5 (0=No,1=Yes) 200 NPH5PVIS Num 3 1258 QV of First Occur. of Pers. Neph Level 5 182 NPHIPFLG Num 3 1204 First Occ of Pers Nph Imprv (0=No,1=Yes) 203 NPHIPVIS Num 3 1267 QV of First Occ of Pers Neph Improvement 3 PHASE Num 3 17 Phase Randomized (2,3) 231 PREG Num 8 1431 Pregnant during DCCT (0=NO,1=Yes) 25 PROTEIN Num 8 103 Dietary Protein (gm) at Baseline 33 QCHOL Num 3 152 Quartile of Cholesterol (mg/dl) at Base 220 QCREAT Num 3 1348 Quartiles: Creatinine Clearance-Baseline The SAS System 13 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 30 QHBAEL Num 3 143 Quartile of HbA1c (%) at Eligibility 34 QHDL Num 3 155 Quartile of HDL Chol (mg/dl) at Base 35 QLDL Num 3 158 Quartile of LDL Chol (mg/dl) at Base 36 QTRG Num 3 161 Quartile of Triglyc. (mg/dl) at Base 219 RACE Num 3 1345 Race 77 RAWCLR00 Num 8 484 Raw Clearance (ml/mn) at Baseline 78 RAWCLR04 Num 8 492 Raw Clearance (ml/mn) at Year 1 79 RAWCLR08 Num 8 500 Raw Clearance (ml/mn) at Year 2 80 RAWCLR12 Num 8 508 Raw Clearance (ml/mn) at Year 3 81 RAWCLR16 Num 8 516 Raw Clearance (ml/mn) at Year 4 82 RAWCLR20 Num 8 524 Raw Clearance (ml/mn) at Year 5 83 RAWCLR24 Num 8 532 Raw Clearance (ml/mn) at Year 6 84 RAWCLR28 Num 8 540 Raw Clearance (ml/mn) at Year 7 85 RAWCLR32 Num 8 548 Raw Clearance (ml/mn) at Year 8 86 RAWCLR36 Num 8 556 Raw Clearance (ml/mn) at Year 9 213 RAWCLR99 Num 8 1302 Raw Clearance (ml/mn) at Close-Out 2 RETBASE Char 4 13 Baseline Retinopathy Strata (Prim,Sec) 13 RETPAT Num 3 57 Level of Retinopathy (1 - 4) 12 RETPAT00 Num 3 54 Baseline Retinopathy Level (1-9 scale) 128 SBP00 Num 8 892 Systolic Blood Pressure (mm Hg) at Base 129 SBP04 Num 8 900 Systolic Blood Pressure (mm Hg) at Yr 1 130 SBP08 Num 8 908 Systolic Blood Pressure (mm Hg) at Yr 2 131 SBP12 Num 8 916 Systolic Blood Pressure (mm Hg) at Yr 3 132 SBP16 Num 8 924 Systolic Blood Pressure (mm Hg) at Yr 4 133 SBP20 Num 8 932 Systolic Blood Pressure (mm Hg) at Yr 5 134 SBP24 Num 8 940 Systolic Blood Pressure (mm Hg) at Yr 6 135 SBP28 Num 8 948 Systolic Blood Pressure (mm Hg) at Yr 7 136 SBP32 Num 8 956 Systolic Blood Pressure (mm Hg) at Yr 8 137 SBP36 Num 8 964 Systolic Blood Pressure (mm Hg) at Yr 9 67 SCR00 Num 8 404 Serum Creatinine (mg/dl) at Base 68 SCR04 Num 8 412 Serum Creatinine (mg/dl) at Yr 1 69 SCR08 Num 8 420 Serum Creatinine (mg/dl) at Yr 2 70 SCR12 Num 8 428 Serum Creatinine (mg/dl) at Yr 3 71 SCR16 Num 8 436 Serum Creatinine (mg/dl) at Yr 4 72 SCR20 Num 8 444 Serum Creatinine (mg/dl) at Yr 5 73 SCR24 Num 8 452 Serum Creatinine (mg/dl) at Yr 6 74 SCR28 Num 8 460 Serum Creatinine (mg/dl) at Yr 7 75 SCR32 Num 8 468 Serum Creatinine (mg/dl) at Yr 8 76 SCR36 Num 8 476 Serum Creatinine (mg/dl) at Yr 9 188 SCR2FLG Num 3 1222 Serum Creatinine >= 2.0 (0=No,1=Yes) 209 SCR2VIS Num 3 1285 QV of Serum Creatinine >= 2.0 14 SMOKES Num 3 60 Smoking Status at Baseline (1 - 3) 31 TMBP Num 3 146 Tertile of Mean Blood Pressure at Base 32 TPROT Num 3 149 Tertile of Dietary Protein (gm) at Base 29 TRG Num 8 135 Triglycerides (mg/dl) at Baseline 16 UTI Num 3 66 Hist of Urinary Tract Infct (0=No,1=Yes) 9 WEIGHT Num 8 40 Weight (kg) at Baseline The SAS System 14 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.MS4EXPRT Observations: 1441 Member Type: DATA Variables: 364 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 2051 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 65536 Number of Data Set Pages: 48 File Format: 607 First Data Page: 1 Max Obs per Page: 31 Obs in First Data Page: 9 File Name: /home/squid/will/DCCT_Cpep/ms4exprt.ssd01 Inode Number: 259794 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 3153920 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 335 ABNC_C04 Num 3 1831 Status change, 2+ nerves abnormal: QV 04 336 ABNC_C08 Num 3 1834 Status change, 2+ nerves abnormal: QV 08 283 ABNC_C20 Num 8 1555 Status change, 2+ nerves abnormal: QV 20 310 ABNC_C99 Num 8 1711 Status change, 2+ nerves abn.: close-out 337 ABN_1C04 Num 3 1837 Status change, 1+ nerve abnormal: QV 04 338 ABN_1C08 Num 3 1840 Status change, 1+ nerve abnormal: QV 08 284 ABN_1C20 Num 8 1563 Status change, 1+ nerve abnormal: QV 20 311 ABN_1C99 Num 8 1719 Status change, 1+ nerve abn: close-out 91 ABN_1_00 Num 3 473 Conduction abnormal 1+ nerve: baseline 117 ABN_1_04 Num 3 606 Conduction abnormal in 1+ nerve: QV 04 151 ABN_1_08 Num 3 802 Conduction abnormal in 1+ nerve: QV 08 214 ABN_1_20 Num 3 1184 Conduction abnormal in 1+ nerve: QV 20 255 ABN_1_99 Num 3 1406 Conduction abnormal 1+ nerve: close-out 85 ABSENT00 Num 3 455 At least 1 unelicitable respon: baseline 111 ABSENT04 Num 3 588 At least 1 unelicitable response: QV 04 145 ABSENT08 Num 3 784 At least 1 unelicitable response: QV 08 208 ABSENT20 Num 3 1166 At least 1 unelicitable response: QV 20 249 ABSENT99 Num 3 1388 At least 1 unelicitable resp: close-out 333 ABST_C04 Num 3 1825 Status change, 1+ unelicitable: QV 04 334 ABST_C08 Num 3 1828 Status change, 1+ unelicitable: QV 08 270 ABST_C20 Num 3 1456 Status change, 1+ unelicitable: QV 20 297 ABST_C99 Num 3 1612 Status change 1+ unelicitable: close-out 19 AFT00 Num 3 54 Abnormal autonomic function: baseline 20 AFT08 Num 3 57 Abnormal autonomic function: QV 08 21 AFT16 Num 3 60 Abnormal autonomic function: QV 16 22 AFT24 Num 3 63 Abnormal autonomic function: QV 24 23 AFT32 Num 3 66 Abnormal autonomic function: QV 32 24 AFT99 Num 3 69 Abnormal autonomic function: close-out The SAS System 15 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 318 AFT_C99 Num 8 1775 Status change, abnormal AFT: close-out 33 AGE Num 8 110 Age at randomization (calculated) 93 AGEGROUP Num 8 479 Age group: < 20 = 1, 20-29 = 2, 30+ = 3 83 AMPS_00 Num 3 449 At least 1 reduced amplitude: baseline 109 AMPS_04 Num 3 582 At least 1 reduced amplitude: QV 04 143 AMPS_08 Num 3 778 At least 1 reduced amplitude: QV 08 206 AMPS_20 Num 3 1160 At least 1 reduced amplitude: QV 20 247 AMPS_99 Num 3 1382 At least 1 reduced amplitude: close-out 329 AMPS_C04 Num 3 1813 Status change, 1+ reduced ampl.: QV 04 330 AMPS_C08 Num 3 1816 Status change, 1+ reduced ampl.: QV 08 268 AMPS_C20 Num 3 1450 Status change, 1+ reduced ampl.: QV 20 295 AMPS_C99 Num 3 1606 Status change, 1+ reduced amp: close-out 39 ANSCLVIS Num 3 158 QV number of close-out ANS tests 103 ANS_QRTL Num 8 539 Quartile of O'Brien score: baseline ANS 26 ANYLOWRR Num 3 75 Reduced RR variation at any time 25 ANYORTHO Num 3 72 Orthostatic hypotension at any time 27 ANYRRVAL Num 3 78 Reduced RR and Valsalva at any time 28 ANY_AFT Num 3 81 Abnormal autonomic function at any time 34 BMI00 Num 8 118 5.1 Body mass index (kg/m**2): baseline 257 BMI04 Num 8 1412 5.1 Body mass index (kg/m**2): QV 04 35 BMI08 Num 8 126 5.1 Body mass index (kg/m**2): QV 08 36 BMI16 Num 8 134 5.1 Body mass index (kg/m**2): QV 16 200 BMI20 Num 8 1137 Body mass index (kg/m**2): QV 20 37 BMI24 Num 8 142 5.1 Body mass index (kg/m**2): QV 24 38 BMI32 Num 8 150 5.1 Body mass index (kg/m**2): QV 32 53 BMI99 Num 8 260 Body mass index: overall close-out visit 106 BMIGROUP Num 8 563 BMI: 0 = below, 1 = above gender median 285 BMI_C20 Num 8 1571 Change in BMI from baseline: QV 20 312 BMI_C99 Num 8 1727 Change in BMI from baseline: close-out 40 CFLGANS Num 3 161 ANS close-out reg vis? (0=n/1=y/.=none) 262 DIAG_C20 Num 3 1432 Change in clinical diagnosis: QV 20 289 DIAG_C99 Num 3 1588 Change in clinical diagnosis: close-out 98 DRINKS Num 3 504 Alcohol user at baseline (1=yes, 0=no) 95 DUR5 Num 3 490 Duration >= 5 (0=no/1=yes) 32 DURATION Num 8 102 Duration of IDDM (Total Months) 238 EMGCLVIS Num 3 1350 QV number of close-out nerve-conduction 104 EMG_QRTL Num 8 547 Quartile of O'Brien score: baseline EMG 92 FOLLOWUP Num 3 476 Length of follow-up (coded 1 through 4) 84 FWAVES00 Num 3 452 1+ prolonged F-wave latency: baseline 110 FWAVES04 Num 3 585 1+ prolonged F-wave latency: QV 04 144 FWAVES08 Num 3 781 1+ prolonged F-wave latency: QV 08 207 FWAVES20 Num 3 1163 1+ prolonged F-wave latency: QV 20 248 FWAVES99 Num 3 1385 1+ prolonged F-wave latency: close-out 331 FW_C04 Num 3 1819 Status change, 1+ prolongd F-wave: QV 04 332 FW_C08 Num 3 1822 Status change, 1+ prolongd F-wave: QV 08 269 FW_C20 Num 3 1453 Status change, 1+ prolongd F-wave: QV 20 296 FW_C99 Num 3 1609 Status change, 1+ long F-wave: close-out 29 GROUP Char 13 84 Treatment group 99 HBAEL Num 8 507 Hemoglobin A1c at Eligibility 105 HBA_QRTL Num 8 555 Quartile of HbA1c at baseline 96 HEIGHT Num 8 493 Height 107 HGTGROUP Num 8 571 Height: 0=below, 1 = above gender median 100 LDL_NCEP Num 8 515 Baseline LDL (NCEP category) The SAS System 16 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 7 LOWRR00 Num 3 18 R-R variation below 15: baseline 8 LOWRR08 Num 3 21 R-R variation below 15: QV 08 9 LOWRR16 Num 3 24 R-R variation below 15: QV 16 10 LOWRR24 Num 3 27 R-R variation below 15: QV 24 11 LOWRR32 Num 3 30 R-R variation below 15: QV 32 12 LOWRR99 Num 3 33 R-R variation below 15: close-out 315 LOWRRC99 Num 8 1751 Status change, RR var'n < 15: close-out 364 MASK_PAT Num 8 2043 Patient ID number 54 MMDA_00 Num 8 268 Median motor distal ampl. (mV): baseline 118 MMDA_04 Num 8 609 Median motor distal ampl. (mV): QV 04 152 MMDA_08 Num 8 805 Median motor distal ampl. (mV): QV 08 176 MMDA_20 Num 8 971 Median motor distal ampl. (mV): QV 20 216 MMDA_99 Num 8 1190 Median motor distal amp. (mV): close-out 339 MMDA_C04 Num 8 1843 Change in median motor distal amp: QV 04 345 MMDA_C08 Num 8 1891 Change in median motor distal amp: QV 08 271 MMDA_C20 Num 8 1459 Change in median motor distal amp: QV 20 298 MMDA_C99 Num 8 1615 Change, median motor dist amp: close-out 57 MMD_00 Num 4 292 Median motor test distance, mm: baseline 121 MMD_04 Num 4 633 Median motor test distance (mm): QV 04 155 MMD_08 Num 4 829 Median motor test distance (mm): QV 08 179 MMD_20 Num 4 995 Median motor test distance (mm): QV 20 219 MMD_99 Num 4 1214 Median motor test dist. (mm): close-out 55 MMFW_00 Num 8 276 Median motor F-wave lat (msec): baseline 119 MMFW_04 Num 8 617 Median motor F-wave laten. (msec): QV 04 153 MMFW_08 Num 8 813 Median motor F-wave laten. (msec): QV 08 177 MMFW_20 Num 8 979 Median motor F-wave laten. (msec): QV 20 217 MMFW_99 Num 8 1198 Median motor F-wave lat, msec: close-out 352 MMFW_C04 Num 8 1947 Change, median motor F-wave lat.: QV 04 358 MMFW_C08 Num 8 1995 Change, median motor F-wave lat.: QV 08 278 MMFW_C20 Num 8 1515 Change, median motor F-wave lat.: QV 20 305 MMFW_C99 Num 8 1671 Change, median motor F-wave: close-out 59 MMPA_00 Num 8 304 Median motor prox. ampl. (mV): baseline 123 MMPA_04 Num 8 645 Median motor proximal ampl. (mV): QV 04 157 MMPA_08 Num 8 841 Median motor proximal ampl. (mV): QV 08 181 MMPA_20 Num 8 1007 Median motor proximal ampl. (mV): QV 20 221 MMPA_99 Num 8 1226 Median motor prox. ampl. (mV): close-out 340 MMPA_C04 Num 8 1851 Change in median motor prox. amp.: QV 04 346 MMPA_C08 Num 8 1899 Change in median motor prox. amp.: QV 08 272 MMPA_C20 Num 8 1467 Change in median motor prox. amp.: QV 20 299 MMPA_C99 Num 8 1623 Change, median motor prox amp: close-out 56 MMT1_00 Num 8 284 Median motor pre-test temp (C): baseline 120 MMT1_04 Num 8 625 Median motor pre-test temp. (C): QV 04 154 MMT1_08 Num 8 821 Median motor pre-test temp. (C): QV 08 178 MMT1_20 Num 8 987 Median motor pre-test temp. (C): QV 20 218 MMT1_99 Num 8 1206 Median motor pre-test temp, C: close-out 60 MMT2_00 Num 8 312 Median motor post-test temp, C: baseline 124 MMT2_04 Num 8 653 Median motor post-test temp. (C): QV 04 158 MMT2_08 Num 8 849 Median motor post-test temp. (C): QV 08 182 MMT2_20 Num 8 1015 Median motor post-test temp. (C): QV 20 222 MMT2_99 Num 8 1234 Median motor post-test temp.: close-out 58 MMV_00 Num 8 296 Median motor velocity (m/sec): baseline 122 MMV_04 Num 8 637 Median motor velocity (m/sec): QV 04 156 MMV_08 Num 8 833 Median motor velocity (m/sec): QV 08 The SAS System 17 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 180 MMV_20 Num 8 999 Median motor velocity (m/sec): QV 20 220 MMV_99 Num 8 1218 Median motor velocity (m/sec): close-out 351 MMV_C04 Num 8 1939 Change in median motor velocity: QV 04 357 MMV_C08 Num 8 1987 Change in median motor velocity: QV 08 277 MMV_C20 Num 8 1507 Change in median motor velocity: QV 20 304 MMV_C99 Num 8 1663 Change, median motor velocity: close-out 86 MM_ABN00 Num 3 458 Median motor cond. abnormality: baseline 112 MM_ABN04 Num 3 591 Median motor cond. abnormality: QV 04 146 MM_ABN08 Num 3 787 Median motor cond. abnormality: QV 08 209 MM_ABN20 Num 3 1169 Median motor cond. abnormality: QV 20 250 MM_ABN99 Num 3 1391 Median motor cond. abnormal: close-out 319 MM_C04 Num 3 1783 Status change, median motor abn.: QV 04 320 MM_C08 Num 3 1786 Status change, median motor abn.: QV 08 263 MM_C20 Num 3 1435 Status change, median motor abn.: QV 20 290 MM_C99 Num 3 1591 Status change, med. motor abn: close-out 76 MSA_00 Num 3 428 Median sensory amplitude (uV): baseline 140 MSA_04 Num 3 769 Median sensory amplitude (uV): QV 04 174 MSA_08 Num 3 965 Median sensory amplitude (uV): QV 08 198 MSA_20 Num 3 1131 Median sensory amplitude (uV): QV 20 239 MSA_99 Num 3 1353 Median sensory amplitude (uV): close-out 341 MSA_C04 Num 8 1859 Change, median sensory amplitude: QV 04 347 MSA_C08 Num 8 1907 Change, median sensory amplitude: QV 08 273 MSA_C20 Num 8 1475 Change, median sensory amplitude: QV 20 300 MSA_C99 Num 8 1631 Change in median sensory amp.: close-out 62 MSD_00 Num 4 328 Median sensory distance (mm): baseline 126 MSD_04 Num 4 669 Median sensory test distance (mm): QV 04 160 MSD_08 Num 4 865 Median sensory test distance (mm): QV 08 184 MSD_20 Num 4 1031 Median sensory test distance (mm): QV 20 224 MSD_99 Num 4 1250 Median sensory distance (mm): close-out 61 MST1_00 Num 8 320 Median sensory pre-test temp.: baseline 125 MST1_04 Num 8 661 Median sensory pre-test temp. (C): QV 04 159 MST1_08 Num 8 857 Median sensory pre-test temp. (C): QV 08 183 MST1_20 Num 8 1023 Median sensory pre-test temp. (C): QV 20 223 MST1_99 Num 8 1242 Median sensory pre-test temp.: close-out 64 MST2_00 Num 8 340 Median sensory post-test temp.: baseline 128 MST2_04 Num 8 681 Median sensory post-test temp (C): QV 04 162 MST2_08 Num 8 877 Median sensory post-test temp (C): QV 08 186 MST2_20 Num 8 1043 Median sensory post-test temp (C): QV 20 226 MST2_99 Num 8 1262 Median sensory post-test temp: close-out 63 MSV_00 Num 8 332 Median sensory velocity, m/sec: baseline 127 MSV_04 Num 8 673 Median sensory velocity (m/sec): QV 04 161 MSV_08 Num 8 869 Median sensory velocity (m/sec): QV 08 185 MSV_20 Num 8 1035 Median sensory velocity (m/sec): QV 20 225 MSV_99 Num 8 1254 Median sensory veloc. (m/sec): close-out 353 MSV_C04 Num 8 1955 Change in median sensory velocity: QV 04 359 MSV_C08 Num 8 2003 Change in median sensory velocity: QV 08 279 MSV_C20 Num 8 1523 Change in median sensory velocity: QV 20 306 MSV_C99 Num 8 1679 Change in median sensory vel.: close-out 87 MS_ABN00 Num 3 461 Median sensory cond. abnormal: baseline 113 MS_ABN04 Num 3 594 Median sensory cond. abnormality: QV 04 147 MS_ABN08 Num 3 790 Median sensory cond. abnormality: QV 08 210 MS_ABN20 Num 3 1172 Median sensory cond. abnormality: QV 20 251 MS_ABN99 Num 3 1394 Median sensory cond. abnormal: close-out The SAS System 18 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 321 MS_C04 Num 3 1789 Status change, median sensory abn: QV 04 322 MS_C08 Num 3 1792 Status change, median sensory abn: QV 08 264 MS_C20 Num 3 1438 Status change, median sensory abn: QV 20 291 MS_C99 Num 3 1594 Status change, med. sens. abn: close-out 363 NCBMIC99 Num 8 2035 Change in BMI: nerve-cond. close-out QV 241 NCBMI_99 Num 8 1359 Body mass index: close-out EMG visit 90 NC_ABN00 Num 3 470 Conduction abnormal 2+ nerves: baseline 116 NC_ABN04 Num 3 603 Conduction abnormal in 2+ nerves: QV 04 150 NC_ABN08 Num 3 799 Conduction abnormal in 2+ nerves: QV 08 213 NC_ABN20 Num 3 1181 Conduction abnormal in 2+ nerves: QV 20 254 NC_ABN99 Num 3 1403 Conduction abnormal 2+ nerves: close-out 94 NDEF_00 Num 3 487 Neuropathy (analytic def, 1=y): baseline 215 NDEF_20 Num 3 1187 Neuropathy (analytic def'n, 1=y): QV 20 256 NDEF_99 Num 3 1409 Neuropathy (analytic def'n): close-out 81 NDIAG_00 Num 3 443 Neuropathy (clin. diagnosis): baseline 204 NDIAG_20 Num 3 1154 Neuropathy (clinical diagnosis): QV 20 245 NDIAG_99 Num 3 1376 Neuropathy (clin. diagnosis): close-out 101 OB_ANS Num 8 523 O'Brien score: Baseline ANS 102 OB_NC Num 8 531 O'Brien score: Baseline nerve conduction 1 ORTHO00 Num 3 0 Orthostatic hypotension: baseline 2 ORTHO08 Num 3 3 Orthostatic hypotension: QV 08 3 ORTHO16 Num 3 6 Orthostatic hypotension: QV 16 4 ORTHO24 Num 3 9 Orthostatic hypotension: QV 24 5 ORTHO32 Num 3 12 Orthostatic hypotension: QV 32 6 ORTHO99 Num 3 15 Orthostatic hypotension: close-out 317 ORTH_C99 Num 8 1767 Status change, ortho. hypoten: close-out 65 PDA_00 Num 8 348 Peroneal distal amplitude (mV): baseline 129 PDA_04 Num 8 689 Peroneal distal amplitude (mV): QV 04 163 PDA_08 Num 8 885 Peroneal distal amplitude (mV): QV 08 187 PDA_20 Num 8 1051 Peroneal distal amplitude (mV): QV 20 227 PDA_99 Num 8 1270 Peroneal distal amplitude, mV: close-out 342 PDA_C04 Num 8 1867 Change in peroneal distal ampl.: QV 04 348 PDA_C08 Num 8 1915 Change in peroneal distal ampl.: QV 08 274 PDA_C20 Num 8 1483 Change in peroneal distal ampl.: QV 20 301 PDA_C99 Num 8 1639 Change in peroneal distal amp: close-out 67 PD_00 Num 4 364 Peroneal test distance (mm): baseline 131 PD_04 Num 4 705 Peroneal test distance (mm): QV 04 165 PD_08 Num 4 901 Peroneal test distance (mm): QV 08 189 PD_20 Num 4 1067 Peroneal test distance (mm): QV 20 229 PD_99 Num 4 1286 Peroneal test distance (mm): close-out 71 PFW_00 Num 8 392 Peroneal F-wave latency (msec): baseline 135 PFW_04 Num 8 733 Peroneal F-wave latency (msec): QV 04 169 PFW_08 Num 8 929 Peroneal F-wave latency (msec): QV 08 193 PFW_20 Num 8 1095 Peroneal F-wave latency (msec): QV 20 233 PFW_99 Num 8 1314 Peroneal F-wave latency, msec: close-out 355 PFW_C04 Num 8 1971 Change in peroneal F-wave latency: QV 04 361 PFW_C08 Num 8 2019 Change in peroneal F-wave latency: QV 08 281 PFW_C20 Num 8 1539 Change in peroneal F-wave latency: QV 20 308 PFW_C99 Num 8 1695 Change, peroneal F-wave lat.: close-out 258 PHASE Num 3 1420 Phase of randomization (2 or 3) 69 PPA_00 Num 8 376 Peroneal proximal amp. (mV): baseline 133 PPA_04 Num 8 717 Peroneal proximal amplitude (mV): QV 04 167 PPA_08 Num 8 913 Peroneal proximal amplitude (mV): QV 08 The SAS System 19 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 191 PPA_20 Num 8 1079 Peroneal proximal amplitude (mV): QV 20 231 PPA_99 Num 8 1298 Peroneal proximal amp. (mV): close-out 343 PPA_C04 Num 8 1875 Change in peroneal proximal amp.: QV 04 349 PPA_C08 Num 8 1923 Change in peroneal proximal amp.: QV 08 275 PPA_C20 Num 8 1491 Change in peroneal proximal amp.: QV 20 302 PPA_C99 Num 8 1647 Change in peroneal prox. amp.: close-out 66 PT1_00 Num 8 356 Peroneal pre-test temp. (C): baseline 130 PT1_04 Num 8 697 Peroneal pre-test temp. (C): QV 04 164 PT1_08 Num 8 893 Peroneal pre-test temp. (C): QV 08 188 PT1_20 Num 8 1059 Peroneal pre-test temp. (C): QV 20 228 PT1_99 Num 8 1278 Peroneal pre-test temp. (C): close-out 70 PT2_00 Num 8 384 Peroneal post-test temp. (C): baseline 134 PT2_04 Num 8 725 Peroneal post-test temp. (C): QV 04 168 PT2_08 Num 8 921 Peroneal post-test temp. (C): QV 08 192 PT2_20 Num 8 1087 Peroneal post-test temp. (C): QV 20 232 PT2_99 Num 8 1306 Peroneal post-test temp. (C): close-out 68 PV_00 Num 8 368 Peroneal velocity (m/sec): baseline 132 PV_04 Num 8 709 Peroneal velocity (m/sec): QV 04 166 PV_08 Num 8 905 Peroneal velocity (m/sec): QV 08 190 PV_20 Num 8 1071 Peroneal velocity (m/sec): QV 20 230 PV_99 Num 8 1290 Peroneal velocity (m/sec): close-out 354 PV_C04 Num 8 1963 Change in peroneal velocity: QV 04 360 PV_C08 Num 8 2011 Change in peroneal velocity: QV 08 280 PV_C20 Num 8 1531 Change in peroneal velocity: QV 20 307 PV_C99 Num 8 1687 Change in peroneal velocity: close-out 88 P_ABN00 Num 3 464 Peroneal conduction abnormal: baseline 114 P_ABN04 Num 3 597 Peroneal conduction abnormality: QV 04 148 P_ABN08 Num 3 793 Peroneal conduction abnormality: QV 08 211 P_ABN20 Num 3 1175 Peroneal conduction abnormality: QV 20 252 P_ABN99 Num 3 1397 Peroneal conduction abnormal: close-out 323 P_C04 Num 3 1795 Status change, peroneal abnormal: QV 04 324 P_C08 Num 3 1798 Status change, peroneal abnormal: QV 08 265 P_C20 Num 3 1441 Status change, peroneal abnormal: QV 20 292 P_C99 Num 3 1597 Status change, peroneal abn.: close-out 80 REFLX_00 Num 3 440 Decreased deep-tendon reflexes: baseline 203 REFLX_20 Num 3 1151 Decreased deep-tendon reflexes: QV 20 244 REFLX_99 Num 3 1373 Decreased deep-tendon reflex: close-out 261 REFL_C20 Num 3 1429 Status change, decreased reflexes: QV 20 288 REFL_C99 Num 3 1585 Status change, decr. reflexes: close-out 30 RETBASE Char 4 97 Retinopathy at Baseline (Prim,Scnd) 41 RRV00 Num 8 164 R-R variation (x 1000): baseline 42 RRV08 Num 8 172 R-R variation (x 1000): QV 08 43 RRV16 Num 8 180 R-R variation (x 1000): QV 16 44 RRV24 Num 8 188 R-R variation (x 1000): QV 24 45 RRV32 Num 8 196 R-R variation (x 1000): QV 32 46 RRV99 Num 8 204 R-R variation (x 1000): close-out 13 RRVAL00 Num 3 36 Low RR & Valsalva ratio: baseline 14 RRVAL08 Num 3 39 Low RR & Valsalva ratio: QV 08 15 RRVAL16 Num 3 42 Low RR & Valsalva ratio: QV 16 16 RRVAL24 Num 3 45 Low RR & Valsalva ratio: QV 24 17 RRVAL32 Num 3 48 Low RR & Valsalva ratio: QV 32 18 RRVAL99 Num 3 51 Low RR & Valsalva ratio: close-out 313 RRV_C99 Num 8 1735 Change in R-R variation: close-out The SAS System 20 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 316 RVAL_C99 Num 8 1759 Status change, low RR & Vals.: close-out 77 SA_00 Num 3 431 Sural amplitude (uV): baseline 141 SA_04 Num 3 772 Sural amplitude (uV): QV 04 175 SA_08 Num 3 968 Sural amplitude (uV): QV 08 199 SA_20 Num 3 1134 Sural amplitude (uV): QV 20 240 SA_99 Num 3 1356 Sural amplitude (uV): close-out 344 SA_C04 Num 8 1883 Change in sural amplitude: QV 04 350 SA_C08 Num 8 1931 Change in sural amplitude: QV 08 276 SA_C20 Num 8 1499 Change in sural amplitude: QV 20 303 SA_C99 Num 8 1655 Change in sural amplitude: close-out 73 SD_00 Num 4 408 Sural test distance (mm): baseline 137 SD_04 Num 4 749 Sural test distance (mm): QV 04 171 SD_08 Num 4 945 Sural test distance (mm): QV 08 195 SD_20 Num 4 1111 Sural test distance (mm): QV 20 235 SD_99 Num 4 1330 Sural test distance (mm): close-out 31 SEX Char 1 101 Patient's gender (from Form 001) 79 SIGNS_00 Num 3 437 Sensory signs of neuropathy: baseline 202 SIGNS_20 Num 3 1148 Sensory signs of neuropathy: QV 20 243 SIGNS_99 Num 3 1370 Sensory signs of neuropathy: close-out 259 SIGN_C20 Num 3 1423 Status change, sensory signs: QV 20 286 SIGN_C99 Num 3 1579 Status change, sensory signs: close-out 97 SMOKES Num 3 501 Smoking Status(1=never,2=ever,3=current) 72 ST1_00 Num 8 400 Sural pre-test temp. (C): baseline 136 ST1_04 Num 8 741 Sural pre-test temp. (C): QV 04 170 ST1_08 Num 8 937 Sural pre-test temp. (C): QV 08 194 ST1_20 Num 8 1103 Sural pre-test temp. (C): QV 20 234 ST1_99 Num 8 1322 Sural pre-test temp. (C): close-out 75 ST2_00 Num 8 420 Sural post-test temp. (C): baseline 139 ST2_04 Num 8 761 Sural post-test temp. (C): QV 04 173 ST2_08 Num 8 957 Sural post-test temp. (C): QV 08 197 ST2_20 Num 8 1123 Sural post-test temp. (C): QV 20 237 ST2_99 Num 8 1342 Sural post-test temp. (C): close-out 74 SV_00 Num 8 412 Sural velocity (m/sec): baseline 138 SV_04 Num 8 753 Sural velocity (m/sec): QV 04 172 SV_08 Num 8 949 Sural velocity (m/sec): QV 08 196 SV_20 Num 8 1115 Sural velocity (m/sec): QV 20 236 SV_99 Num 8 1334 Sural velocity (m/sec): close-out 356 SV_C04 Num 8 1979 Change in sural velocity: QV 04 362 SV_C08 Num 8 2027 Change in sural velocity: QV 08 282 SV_C20 Num 8 1547 Change in sural velocity: QV 20 309 SV_C99 Num 8 1703 Change in sural velocity: close-out 78 SYMPT_00 Num 3 434 Symptoms of neuropathy: baseline 201 SYMPT_20 Num 3 1145 Symptoms of neuropathy: QV 20 242 SYMPT_99 Num 3 1367 Symptoms of neuropathy: close-out 260 SYMP_C20 Num 3 1426 Status change, neur. symptoms: QV 20 287 SYMP_C99 Num 3 1582 Status change, neur. symptoms: close-out 89 S_ABN00 Num 3 467 Sural conduction abnormality: baseline 115 S_ABN04 Num 3 600 Sural conduction abnormality: QV 04 149 S_ABN08 Num 3 796 Sural conduction abnormality: QV 08 212 S_ABN20 Num 3 1178 Sural conduction abnormality: QV 20 253 S_ABN99 Num 3 1400 Sural conduction abnormality: close-out 325 S_C04 Num 3 1801 Status change, sural abnormality: QV 04 326 S_C08 Num 3 1804 Status change, sural abnormality: QV 08 The SAS System 21 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 266 S_C20 Num 3 1444 Status change, sural abnormality: QV 20 293 S_C99 Num 3 1600 Status change, sural abnormal: close-out 47 VALS00 Num 8 212 Mean Valsalva ratio: baseline 48 VALS08 Num 8 220 Mean Valsalva ratio: QV 08 49 VALS16 Num 8 228 Mean Valsalva ratio: QV 16 50 VALS24 Num 8 236 Mean Valsalva ratio: QV 24 51 VALS32 Num 8 244 Mean Valsalva ratio: QV 32 52 VALS99 Num 8 252 Mean Valsalva ratio: close-out 314 VAL_C99 Num 8 1743 Change in Valsalva ratio: close-out 82 VELS_00 Num 3 446 1 or more reduced velocity: baseline 108 VELS_04 Num 3 579 1 or more reduced cond. velocity: QV 04 142 VELS_08 Num 3 775 1 or more reduced cond. velocity: QV 08 205 VELS_20 Num 3 1157 1 or more reduced cond. velocity: QV 20 246 VELS_99 Num 3 1379 1 or more reduced velocity: close-out 327 VELS_C04 Num 3 1807 Status change, 1+ reduced veloc.: QV 04 328 VELS_C08 Num 3 1810 Status change, 1+ reduced veloc.: QV 08 267 VELS_C20 Num 3 1447 Status change, 1+ reduced veloc.: QV 20 294 VELS_C99 Num 3 1603 Status change, 1+ reduced vel: close-out The SAS System 22 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.MS5EVENT Observations: 274 Member Type: DATA Variables: 12 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 107 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 16384 Number of Data Set Pages: 2 File Format: 607 First Data Page: 1 Max Obs per Page: 152 Obs in First Data Page: 135 File Name: /home/squid/will/DCCT_Cpep/ms5event.ssd01 Inode Number: 259833 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 40960 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 10 AGE Num 8 83 Age at randomization (calculated) 8 DEGREE Char 5 77 Degree of disease (major, other, nil) 7 DISEASE Char 3 74 Type of disease (death, CAD, CVD, PVD) 1 EVENT Char 40 0 Description of event 4 EVT_CODE Num 3 54 Event code 3 EVT_DATE Num 4 50 MMDDYY8. Date of event 12 EVT_TIME Num 8 99 Time of event (years from randomization) 5 GROUP Char 13 57 Treatment group 11 MASK_PAT Num 8 91 Patient ID number 2 ORIGIN Char 10 40 Source of event data 6 RETBASE Char 4 70 Baseline retinopathy stratum 9 SEX Char 1 82 Patient's gender (from Form 001) The SAS System 23 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE Data Set Name: ABC.MS5EXPRT Observations: 1441 Member Type: DATA Variables: 518 Engine: V612 Indexes: 0 Created: 14:13 Monday, February 2, 1998 Observation Length: 2918 Last Modified: 14:13 Monday, February 2, 1998 Deleted Observations: 0 Protection: Compressed: NO Data Set Type: Sorted: NO Label: -----Engine/Host Dependent Information----- Data Set Page Size: 65536 Number of Data Set Pages: 67 File Format: 607 First Data Page: 2 Max Obs per Page: 22 Obs in First Data Page: 22 File Name: /home/squid/will/DCCT_Cpep/ms5exprt.ssd01 Inode Number: 259834 Access Permission: rw-r--r-- Owner Name: will File Size (bytes): 4399104 -----Alphabetic List of Variables and Attributes----- # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 391 ADOLESCT Num 8 2504 Randomized as an adolescent (0=n, 1=y) 170 AER00 Num 8 1222 Albumin excretion rate, mg/day: baseline 211 AER_GE40 Num 8 1390 Baseline AER => 40 (0 = no, 1 = yes) 516 AGE Num 8 2894 Age at randomization (calculated) 393 AGE_QRTL Num 8 2520 Quartile of baseline age 362 ALCPCT00 Num 8 2278 Alcohol as % of total calories: baseline 363 ALCPCT08 Num 8 2286 Alcohol as % of total calories: QV 08 364 ALCPCT20 Num 8 2294 Alcohol as % of total calories: QV 20 337 ALCPCT99 Num 8 2078 Alcohol, % of total calories: close-out 1 BGPX_00 Num 8 0 Mean profile blood glucose: baseline 2 BGPX_04 Num 8 8 Mean blood glucose from profile: QV 04 3 BGPX_08 Num 8 16 Mean blood glucose from profile: QV 08 4 BGPX_12 Num 8 24 Mean blood glucose from profile: QV 12 5 BGPX_16 Num 8 32 Mean blood glucose from profile: QV 16 6 BGPX_20 Num 8 40 Mean blood glucose from profile: QV 20 7 BGPX_24 Num 8 48 Mean blood glucose from profile: QV 24 8 BGPX_28 Num 8 56 Mean blood glucose from profile: QV 28 9 BGPX_32 Num 8 64 Mean blood glucose from profile: QV 32 10 BGPX_36 Num 8 72 Mean blood glucose from profile: QV 36 518 BIA_TIME Num 8 2910 Time of BIA (years after randomization) 22 BMI00 Num 8 128 5.1 Body mass index (kg/m**2): baseline 25 BMI01 Num 8 152 5.1 Body mass index (kg/m**2): QV 01 28 BMI02 Num 8 176 5.1 Body mass index (kg/m**2): QV 02 31 BMI03 Num 8 200 5.1 Body mass index (kg/m**2): QV 03 38 BMI04 Num 8 246 5.1 Body mass index (kg/m**2): QV 04 41 BMI05 Num 8 270 5.1 Body mass index (kg/m**2): QV 05 44 BMI06 Num 8 294 5.1 Body mass index (kg/m**2): QV 06 47 BMI07 Num 8 318 5.1 Body mass index (kg/m**2): QV 07 The SAS System 24 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 54 BMI08 Num 8 364 5.1 Body mass index (kg/m**2): QV 08 57 BMI09 Num 8 388 5.1 Body mass index (kg/m**2): QV 09 60 BMI10 Num 8 412 5.1 Body mass index (kg/m**2): QV 10 63 BMI11 Num 8 436 5.1 Body mass index (kg/m**2): QV 11 70 BMI12 Num 8 482 5.1 Body mass index (kg/m**2): QV 12 73 BMI13 Num 8 506 5.1 Body mass index (kg/m**2): QV 13 76 BMI14 Num 8 530 5.1 Body mass index (kg/m**2): QV 14 79 BMI15 Num 8 554 5.1 Body mass index (kg/m**2): QV 15 86 BMI16 Num 8 600 5.1 Body mass index (kg/m**2): QV 16 89 BMI17 Num 8 624 5.1 Body mass index (kg/m**2): QV 17 92 BMI18 Num 8 648 5.1 Body mass index (kg/m**2): QV 18 95 BMI19 Num 8 672 5.1 Body mass index (kg/m**2): QV 19 102 BMI20 Num 8 718 5.1 Body mass index (kg/m**2): QV 20 105 BMI21 Num 8 742 5.1 Body mass index (kg/m**2): QV 21 108 BMI22 Num 8 766 5.1 Body mass index (kg/m**2): QV 22 111 BMI23 Num 8 790 5.1 Body mass index (kg/m**2): QV 23 118 BMI24 Num 8 836 5.1 Body mass index (kg/m**2): QV 24 121 BMI25 Num 8 860 5.1 Body mass index (kg/m**2): QV 25 124 BMI26 Num 8 884 5.1 Body mass index (kg/m**2): QV 26 127 BMI27 Num 8 908 5.1 Body mass index (kg/m**2): QV 27 134 BMI28 Num 8 954 5.1 Body mass index (kg/m**2): QV 28 137 BMI29 Num 8 978 5.1 Body mass index (kg/m**2): QV 29 140 BMI30 Num 8 1002 5.1 Body mass index (kg/m**2): QV 30 143 BMI31 Num 8 1026 5.1 Body mass index (kg/m**2): QV 31 150 BMI32 Num 8 1072 5.1 Body mass index (kg/m**2): QV 32 153 BMI33 Num 8 1096 5.1 Body mass index (kg/m**2): QV 33 156 BMI34 Num 8 1120 5.1 Body mass index (kg/m**2): QV 34 159 BMI35 Num 8 1144 5.1 Body mass index (kg/m**2): QV 35 166 BMI36 Num 8 1190 5.1 Body mass index (kg/m**2): QV 36 344 CALS_00 Num 8 2134 Total calories (kCal): baseline 345 CALS_08 Num 8 2142 Total calories (kCal): QV 08 346 CALS_20 Num 8 2150 Total calories (kCal): QV 20 331 CALS_99 Num 8 2030 Total calories (kCal): close-out 171 CHOL00 Num 4 1230 Total cholesterol (mg/dl): baseline 172 CHOL04 Num 4 1234 Total cholesterol (mg/dl): QV 04 173 CHOL08 Num 4 1238 Total cholesterol (mg/dl): QV 08 174 CHOL12 Num 4 1242 Total cholesterol (mg/dl): QV 12 175 CHOL16 Num 4 1246 Total cholesterol (mg/dl): QV 16 176 CHOL20 Num 4 1250 Total cholesterol (mg/dl): QV 20 177 CHOL24 Num 4 1254 Total cholesterol (mg/dl): QV 24 178 CHOL28 Num 4 1258 Total cholesterol (mg/dl): QV 28 179 CHOL32 Num 4 1262 Total cholesterol (mg/dl): QV 32 180 CHOL36 Num 4 1266 Total cholesterol (mg/dl): QV 36 282 CIGART00 Num 8 1783 Current cigarette smoker: baseline 294 CIGART04 Num 8 1829 Current cigarette smoker: QV 04 295 CIGART08 Num 8 1837 Current cigarette smoker: QV 08 296 CIGART12 Num 8 1845 Current cigarette smoker: QV 12 297 CIGART16 Num 8 1853 Current cigarette smoker: QV 16 298 CIGART20 Num 8 1861 Current cigarette smoker: QV 20 299 CIGART24 Num 8 1869 Current cigarette smoker: QV 24 300 CIGART28 Num 8 1877 Current cigarette smoker: QV 28 301 CIGART32 Num 8 1885 Current cigarette smoker: QV 32 302 CIGART36 Num 8 1893 Current cigarette smoker: QV 36 The SAS System 25 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 321 CUM_PY00 Num 3 2000 Cumulative pack-years smoked: baseline 322 CUM_PY04 Num 3 2003 Cumulative pack-years smoked: QV 04 323 CUM_PY08 Num 3 2006 Cumulative pack-years smoked: QV 08 324 CUM_PY12 Num 3 2009 Cumulative pack-years smoked: QV 12 325 CUM_PY16 Num 3 2012 Cumulative pack-years smoked: QV 16 326 CUM_PY20 Num 3 2015 Cumulative pack-years smoked: QV 20 327 CUM_PY24 Num 3 2018 Cumulative pack-years smoked: QV 24 328 CUM_PY28 Num 3 2021 Cumulative pack-years smoked: QV 28 329 CUM_PY32 Num 3 2024 Cumulative pack-years smoked: QV 32 330 CUM_PY36 Num 3 2027 Cumulative pack-years smoked: QV 36 19 DBP00 Num 3 109 Diastolic blood press. (mm Hg): baseline 35 DBP04 Num 3 227 Diastolic blood pressure (mm Hg): QV 04 51 DBP08 Num 3 345 Diastolic blood pressure (mm Hg): QV 08 67 DBP12 Num 3 463 Diastolic blood pressure (mm Hg): QV 12 83 DBP16 Num 3 581 Diastolic blood pressure (mm Hg): QV 16 99 DBP20 Num 3 699 Diastolic blood pressure (mm Hg): QV 20 115 DBP24 Num 3 817 Diastolic blood pressure (mm Hg): QV 24 131 DBP28 Num 3 935 Diastolic blood pressure (mm Hg): QV 28 147 DBP32 Num 3 1053 Diastolic blood pressure (mm Hg): QV 32 163 DBP36 Num 3 1171 Diastolic blood pressure (mm Hg): QV 36 241 DRINKS00 Num 3 1605 Patient reports using alcohol: baseline 245 DRINKS04 Num 3 1622 Patient reports using alcohol: QV 04 249 DRINKS08 Num 3 1639 Patient reports using alcohol: QV 08 253 DRINKS12 Num 3 1656 Patient reports using alcohol: QV 12 257 DRINKS16 Num 3 1673 Patient reports using alcohol: QV 16 261 DRINKS20 Num 3 1690 Patient reports using alcohol: QV 20 265 DRINKS24 Num 3 1707 Patient reports using alcohol: QV 24 269 DRINKS28 Num 3 1724 Patient reports using alcohol: QV 28 273 DRINKS32 Num 3 1741 Patient reports using alcohol: QV 32 277 DRINKS36 Num 3 1758 Patient reports using alcohol: QV 36 390 DURATION Num 8 2496 Duration of IDDM (Total Months) 392 DUR_CAT Num 8 2512 Category of IDDM duration at baseline 242 EXERCS00 Num 3 1608 Typical level of exercise: baseline 246 EXERCS04 Num 3 1625 Typical level of exercise: QV 04 250 EXERCS08 Num 3 1642 Typical level of exercise: QV 08 254 EXERCS12 Num 3 1659 Typical level of exercise: QV 12 258 EXERCS16 Num 3 1676 Typical level of exercise: QV 16 262 EXERCS20 Num 3 1693 Typical level of exercise: QV 20 266 EXERCS24 Num 3 1710 Typical level of exercise: QV 24 270 EXERCS28 Num 3 1727 Typical level of exercise: QV 28 274 EXERCS32 Num 3 1744 Typical level of exercise: QV 32 278 EXERCS36 Num 3 1761 Typical level of exercise: QV 36 224 FATFREE Num 8 1494 Fat-free body mass (kg) estimated by BIA 350 FATPCT00 Num 8 2182 Fat intake as % total calories: baseline 351 FATPCT08 Num 8 2190 Fat intake as % of total calories: QV 08 352 FATPCT20 Num 8 2198 Fat intake as % of total calories: QV 20 333 FATPCT99 Num 8 2046 Fat intake (% total calories): close-out 228 FHXHLIP Num 3 1516 Family history of hyperlipidemia (1 = y) 226 FHXHTEN Num 3 1510 Family history of hypertension (1 = yes) 227 FHXMI Num 3 1513 Family history of MI (1=y/2=n/3=unknown) 377 FIBER_00 Num 8 2398 Dietary fiber (gm): baseline 378 FIBER_08 Num 8 2406 Dietary fiber (gm): QV 08 379 FIBER_20 Num 8 2414 Dietary fiber (gm): QV 20 The SAS System 26 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 342 FIBER_99 Num 8 2118 Dietary fiber (gm): close-out 230 FSCORE00 Num 8 1522 Framingham risk score for CHD: baseline 231 FSCORE04 Num 8 1530 Framingham risk score for CHD: QV 04 232 FSCORE08 Num 8 1538 Framingham risk score for CHD: QV 08 233 FSCORE12 Num 8 1546 Framingham risk score for CHD: QV 12 234 FSCORE16 Num 8 1554 Framingham risk score for CHD: QV 16 235 FSCORE20 Num 8 1562 Framingham risk score for CHD: QV 20 236 FSCORE24 Num 8 1570 Framingham risk score for CHD: QV 24 237 FSCORE28 Num 8 1578 Framingham risk score for CHD: QV 28 238 FSCORE32 Num 8 1586 Framingham risk score for CHD: QV 32 239 FSCORE36 Num 8 1594 Framingham risk score for CHD: QV 36 387 GROUP Char 13 2478 Treatment group 17 HBA1C00 Num 8 98 HbA1c (percent of hemoglobin): baseline 33 HBA1C04 Num 8 216 HbA1c (percent of hemoglobin): QV 04 49 HBA1C08 Num 8 334 HbA1c (percent of hemoglobin): QV 08 65 HBA1C12 Num 8 452 HbA1c (percent of hemoglobin): QV 12 81 HBA1C16 Num 8 570 HbA1c (percent of hemoglobin): QV 16 97 HBA1C20 Num 8 688 HbA1c (percent of hemoglobin): QV 20 113 HBA1C24 Num 8 806 HbA1c (percent of hemoglobin): QV 24 129 HBA1C28 Num 8 924 HbA1c (percent of hemoglobin): QV 28 145 HBA1C32 Num 8 1042 HbA1c (percent of hemoglobin): QV 32 161 HBA1C36 Num 8 1160 HbA1c (percent of hemoglobin): QV 36 169 HBA_QRTL Num 8 1214 Quartile of HbA1c at baseline 496 HCHOL00 Num 3 2834 LDL cholesterol => 160 mg/dl: baseline 497 HCHOL04 Num 3 2837 LDL cholesterol => 160 mg/dl: QV 04 498 HCHOL08 Num 3 2840 LDL cholesterol => 160 mg/dl: QV 08 499 HCHOL12 Num 3 2843 LDL cholesterol => 160 mg/dl: QV 12 500 HCHOL16 Num 3 2846 LDL cholesterol => 160 mg/dl: QV 16 501 HCHOL20 Num 3 2849 LDL cholesterol => 160 mg/dl: QV 20 502 HCHOL24 Num 3 2852 LDL cholesterol => 160 mg/dl: QV 24 503 HCHOL28 Num 3 2855 LDL cholesterol => 160 mg/dl: QV 28 504 HCHOL32 Num 3 2858 LDL cholesterol => 160 mg/dl: QV 32 505 HCHOL36 Num 3 2861 LDL cholesterol => 160 mg/dl: QV 36 201 HDL00 Num 4 1350 HDL cholesterol (mg/dl): baseline 202 HDL04 Num 4 1354 HDL cholesterol (mg/dl): QV 04 203 HDL08 Num 4 1358 HDL cholesterol (mg/dl): QV 08 204 HDL12 Num 4 1362 HDL cholesterol (mg/dl): QV 12 205 HDL16 Num 4 1366 HDL cholesterol (mg/dl): QV 16 206 HDL20 Num 4 1370 HDL cholesterol (mg/dl): QV 20 207 HDL24 Num 4 1374 HDL cholesterol (mg/dl): QV 24 208 HDL28 Num 4 1378 HDL cholesterol (mg/dl): QV 28 209 HDL32 Num 4 1382 HDL cholesterol (mg/dl): QV 32 210 HDL36 Num 4 1386 HDL cholesterol (mg/dl): QV 36 434 HI_LDL00 Num 3 2648 LDL cholesterol => 130 mg/dl: baseline 435 HI_LDL04 Num 3 2651 LDL cholesterol => 130 mg/dl: QV 04 436 HI_LDL08 Num 3 2654 LDL cholesterol => 130 mg/dl: QV 08 437 HI_LDL12 Num 3 2657 LDL cholesterol => 130 mg/dl: QV 12 438 HI_LDL16 Num 3 2660 LDL cholesterol => 130 mg/dl: QV 16 439 HI_LDL20 Num 3 2663 LDL cholesterol => 130 mg/dl: QV 20 440 HI_LDL24 Num 3 2666 LDL cholesterol => 130 mg/dl: QV 24 441 HI_LDL28 Num 3 2669 LDL cholesterol => 130 mg/dl: QV 28 442 HI_LDL32 Num 3 2672 LDL cholesterol => 130 mg/dl: QV 32 443 HI_LDL36 Num 3 2675 LDL cholesterol => 130 mg/dl: QV 36 The SAS System 27 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 486 HTEN00 Num 3 2804 Unconfirmed hypertension: baseline 487 HTEN04 Num 3 2807 Unconfirmed hypertension: QV 04 488 HTEN08 Num 3 2810 Unconfirmed hypertension: QV 08 489 HTEN12 Num 3 2813 Unconfirmed hypertension: QV 12 490 HTEN16 Num 3 2816 Unconfirmed hypertension: QV 16 491 HTEN20 Num 3 2819 Unconfirmed hypertension: QV 20 492 HTEN24 Num 3 2822 Unconfirmed hypertension: QV 24 493 HTEN28 Num 3 2825 Unconfirmed hypertension: QV 28 494 HTEN32 Num 3 2828 Unconfirmed hypertension: QV 32 495 HTEN36 Num 3 2831 Unconfirmed hypertension: QV 36 506 HTRIG00 Num 3 2864 Triglycerides => 500 mg/dl: baseline 507 HTRIG04 Num 3 2867 Triglycerides => 500 mg/dl: QV 04 508 HTRIG08 Num 3 2870 Triglycerides => 500 mg/dl: QV 08 509 HTRIG12 Num 3 2873 Triglycerides => 500 mg/dl: QV 12 510 HTRIG16 Num 3 2876 Triglycerides => 500 mg/dl: QV 16 511 HTRIG20 Num 3 2879 Triglycerides => 500 mg/dl: QV 20 512 HTRIG24 Num 3 2882 Triglycerides => 500 mg/dl: QV 24 513 HTRIG28 Num 3 2885 Triglycerides => 500 mg/dl: QV 28 514 HTRIG32 Num 3 2888 Triglycerides => 500 mg/dl: QV 32 515 HTRIG36 Num 3 2891 Triglycerides => 500 mg/dl: QV 36 23 IBW00 Num 8 136 5.1 Percent of ideal body weight: baseline 26 IBW01 Num 8 160 5.1 Percent of ideal body weight: QV 01 29 IBW02 Num 8 184 5.1 Percent of ideal body weight: QV 02 32 IBW03 Num 8 208 5.1 Percent of ideal body weight: QV 03 39 IBW04 Num 8 254 5.1 Percent of ideal body weight: QV 04 42 IBW05 Num 8 278 5.1 Percent of ideal body weight: QV 05 45 IBW06 Num 8 302 5.1 Percent of ideal body weight: QV 06 48 IBW07 Num 8 326 5.1 Percent of ideal body weight: QV 07 55 IBW08 Num 8 372 5.1 Percent of ideal body weight: QV 08 58 IBW09 Num 8 396 5.1 Percent of ideal body weight: QV 09 61 IBW10 Num 8 420 5.1 Percent of ideal body weight: QV 10 64 IBW11 Num 8 444 5.1 Percent of ideal body weight: QV 11 71 IBW12 Num 8 490 5.1 Percent of ideal body weight: QV 12 74 IBW13 Num 8 514 5.1 Percent of ideal body weight: QV 13 77 IBW14 Num 8 538 5.1 Percent of ideal body weight: QV 14 80 IBW15 Num 8 562 5.1 Percent of ideal body weight: QV 15 87 IBW16 Num 8 608 5.1 Percent of ideal body weight: QV 16 90 IBW17 Num 8 632 5.1 Percent of ideal body weight: QV 17 93 IBW18 Num 8 656 5.1 Percent of ideal body weight: QV 18 96 IBW19 Num 8 680 5.1 Percent of ideal body weight: QV 19 103 IBW20 Num 8 726 5.1 Percent of ideal body weight: QV 20 106 IBW21 Num 8 750 5.1 Percent of ideal body weight: QV 21 109 IBW22 Num 8 774 5.1 Percent of ideal body weight: QV 22 112 IBW23 Num 8 798 5.1 Percent of ideal body weight: QV 23 119 IBW24 Num 8 844 5.1 Percent of ideal body weight: QV 24 122 IBW25 Num 8 868 5.1 Percent of ideal body weight: QV 25 125 IBW26 Num 8 892 5.1 Percent of ideal body weight: QV 26 128 IBW27 Num 8 916 5.1 Percent of ideal body weight: QV 27 135 IBW28 Num 8 962 5.1 Percent of ideal body weight: QV 28 138 IBW29 Num 8 986 5.1 Percent of ideal body weight: QV 29 141 IBW30 Num 8 1010 5.1 Percent of ideal body weight: QV 30 144 IBW31 Num 8 1034 5.1 Percent of ideal body weight: QV 31 151 IBW32 Num 8 1080 5.1 Percent of ideal body weight: QV 32 The SAS System 28 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 154 IBW33 Num 8 1104 5.1 Percent of ideal body weight: QV 33 157 IBW34 Num 8 1128 5.1 Percent of ideal body weight: QV 34 160 IBW35 Num 8 1152 5.1 Percent of ideal body weight: QV 35 167 IBW36 Num 8 1198 5.1 Percent of ideal body weight: QV 36 243 INSULN00 Num 8 1611 Total insulin dose (units/kg): baseline 247 INSULN04 Num 8 1628 Total insulin dose (units/kg): QV 04 251 INSULN08 Num 8 1645 Total insulin dose (units/kg): QV 08 255 INSULN12 Num 8 1662 Total insulin dose (units/kg): QV 12 259 INSULN16 Num 8 1679 Total insulin dose (units/kg): QV 16 263 INSULN20 Num 8 1696 Total insulin dose (units/kg): QV 20 267 INSULN24 Num 8 1713 Total insulin dose (units/kg): QV 24 271 INSULN28 Num 8 1730 Total insulin dose (units/kg): QV 28 275 INSULN32 Num 8 1747 Total insulin dose (units/kg): QV 32 279 INSULN36 Num 8 1764 Total insulin dose (units/kg): QV 36 280 INS_QRTL Num 8 1772 Quartile of baseline insulin dose (u/kg) 223 IWST_HIP Num 8 1486 Iliac-waist-to-hip ratio 474 I_1HDL Num 3 2768 Indicator: single HDL <= 35 observed 432 I_1LDL Num 3 2642 Indicator: single LDL => 130 observed 446 I_1TRIG2 Num 3 2684 Indicator: single trig => 200 observed 460 I_1TRIG4 Num 3 2726 Indicator: single trig => 400 observed 13 I_HCHOL Num 3 86 Indicator: hypercholesterolemia observed 11 I_HTEN Num 3 80 Indicator: hypertension observed 15 I_HTRIG Num 3 92 Indicator: hypertriglyceridemia observed 406 I_MWG Num 3 2564 Indicator: major weight gain observed 394 I_OBESE Num 3 2528 Indicator: weight > 120% ideal observed 418 I_OVERWT Num 3 2600 Indicator: overweight (by NCHS) observed 472 I_SHDL Num 3 2762 Indicator: sustained HDL <= 35 observed 430 I_SLDL Num 3 2636 Indicator: sustained LDL => 130 observed 444 I_STRIG2 Num 3 2678 Indicator: sustained trig > 200 observed 458 I_STRIG4 Num 3 2720 Indicator: sustained trig > 400 observed 191 LDL00 Num 4 1310 LDL cholesterol (mg/dl): baseline 192 LDL04 Num 4 1314 LDL cholesterol (mg/dl): QV 04 193 LDL08 Num 4 1318 LDL cholesterol (mg/dl): QV 08 194 LDL12 Num 4 1322 LDL cholesterol (mg/dl): QV 12 195 LDL16 Num 4 1326 LDL cholesterol (mg/dl): QV 16 196 LDL20 Num 4 1330 LDL cholesterol (mg/dl): QV 20 197 LDL24 Num 4 1334 LDL cholesterol (mg/dl): QV 24 198 LDL28 Num 4 1338 LDL cholesterol (mg/dl): QV 28 199 LDL32 Num 4 1342 LDL cholesterol (mg/dl): QV 32 200 LDL36 Num 4 1346 LDL cholesterol (mg/dl): QV 36 212 LHR00 Num 8 1398 LDL-to-HDL ratio: baseline 213 LHR04 Num 8 1406 LDL-to-HDL ratio: QV 04 214 LHR08 Num 8 1414 LDL-to-HDL ratio: QV 08 215 LHR12 Num 8 1422 LDL-to-HDL ratio: QV 12 216 LHR16 Num 8 1430 LDL-to-HDL ratio: QV 16 217 LHR20 Num 8 1438 LDL-to-HDL ratio: QV 20 218 LHR24 Num 8 1446 LDL-to-HDL ratio: QV 24 219 LHR28 Num 8 1454 LDL-to-HDL ratio: QV 28 220 LHR32 Num 8 1462 LDL-to-HDL ratio: QV 32 221 LHR36 Num 8 1470 LDL-to-HDL ratio: QV 36 476 LOWHDL00 Num 3 2774 HDL cholesterol <= 35 mg/dl: baseline 477 LOWHDL04 Num 3 2777 HDL cholesterol <= 35 mg/dl: QV 04 478 LOWHDL08 Num 3 2780 HDL cholesterol <= 35 mg/dl: QV 08 The SAS System 29 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 479 LOWHDL12 Num 3 2783 HDL cholesterol <= 35 mg/dl: QV 12 480 LOWHDL16 Num 3 2786 HDL cholesterol <= 35 mg/dl: QV 16 481 LOWHDL20 Num 3 2789 HDL cholesterol <= 35 mg/dl: QV 20 482 LOWHDL24 Num 3 2792 HDL cholesterol <= 35 mg/dl: QV 24 483 LOWHDL28 Num 3 2795 HDL cholesterol <= 35 mg/dl: QV 28 484 LOWHDL32 Num 3 2798 HDL cholesterol <= 35 mg/dl: QV 32 485 LOWHDL36 Num 3 2801 HDL cholesterol <= 35 mg/dl: QV 36 517 MASK_PAT Num 8 2902 Patient ID number 20 MBP00 Num 8 112 5.1 Mean blood pressure (mm Hg): baseline 36 MBP04 Num 8 230 5.1 Mean blood pressure (mm Hg): QV 04 52 MBP08 Num 8 348 5.1 Mean blood pressure (mm Hg): QV 08 68 MBP12 Num 8 466 5.1 Mean blood pressure (mm Hg): QV 12 84 MBP16 Num 8 584 5.1 Mean blood pressure (mm Hg): QV 16 100 MBP20 Num 8 702 5.1 Mean blood pressure (mm Hg): QV 20 116 MBP24 Num 8 820 5.1 Mean blood pressure (mm Hg): QV 24 132 MBP28 Num 8 938 5.1 Mean blood pressure (mm Hg): QV 28 148 MBP32 Num 8 1056 5.1 Mean blood pressure (mm Hg): QV 32 164 MBP36 Num 8 1174 5.1 Mean blood pressure (mm Hg): QV 36 356 MONPCT00 Num 8 2230 Monounsaturated fat (% kCals): baseline 357 MONPCT08 Num 8 2238 Monounsaturated fat (% calories): QV 08 358 MONPCT20 Num 8 2246 Monounsaturated fat (% calories): QV 20 335 MONPCT99 Num 8 2062 Monounsaturated fat (% kCals): close-out 408 MWG00 Num 3 2570 Major weight gain: baseline 409 MWG04 Num 3 2573 Major weight gain: QV 04 410 MWG08 Num 3 2576 Major weight gain: QV 08 411 MWG12 Num 3 2579 Major weight gain: QV 12 412 MWG16 Num 3 2582 Major weight gain: QV 16 413 MWG20 Num 3 2585 Major weight gain: QV 20 414 MWG24 Num 3 2588 Major weight gain: QV 24 415 MWG28 Num 3 2591 Major weight gain: QV 28 416 MWG32 Num 3 2594 Major weight gain: QV 32 417 MWG36 Num 3 2597 Major weight gain: QV 36 222 NWST_HIP Num 8 1478 Natural-waist-to-hip ratio 396 OBESE_00 Num 3 2534 Weight > 120% calculated ideal: baseline 397 OBESE_04 Num 3 2537 Weight > 120% calculated ideal: QV 04 398 OBESE_08 Num 3 2540 Weight > 120% calculated ideal: QV 08 399 OBESE_12 Num 3 2543 Weight > 120% calculated ideal: QV 12 400 OBESE_16 Num 3 2546 Weight > 120% calculated ideal: QV 16 401 OBESE_20 Num 3 2549 Weight > 120% calculated ideal: QV 20 402 OBESE_24 Num 3 2552 Weight > 120% calculated ideal: QV 24 403 OBESE_28 Num 3 2555 Weight > 120% calculated ideal: QV 28 404 OBESE_32 Num 3 2558 Weight > 120% calculated ideal: QV 32 405 OBESE_36 Num 3 2561 Weight > 120% calculated ideal: QV 36 420 OVERWT00 Num 3 2606 Overweight (NHANES definition): baseline 421 OVERWT04 Num 3 2609 Overweight (NHANES definition): QV 04 422 OVERWT08 Num 3 2612 Overweight (NHANES definition): QV 08 423 OVERWT12 Num 3 2615 Overweight (NHANES definition): QV 12 424 OVERWT16 Num 3 2618 Overweight (NHANES definition): QV 16 425 OVERWT20 Num 3 2621 Overweight (NHANES definition): QV 20 426 OVERWT24 Num 3 2624 Overweight (NHANES definition): QV 24 427 OVERWT28 Num 3 2627 Overweight (NHANES definition): QV 28 428 OVERWT32 Num 3 2630 Overweight (NHANES definition): QV 32 429 OVERWT36 Num 3 2633 Overweight (NHANES definition): QV 36 The SAS System 30 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 284 PACKYR00 Num 3 1799 Pack-years smoked before randomization 312 PACKYR04 Num 3 1973 Pack-years smoked in prior year: QV 04 313 PACKYR08 Num 3 1976 Pack-years smoked in prior year: QV 08 314 PACKYR12 Num 3 1979 Pack-years smoked in prior year: QV 12 315 PACKYR16 Num 3 1982 Pack-years smoked in prior year: QV 16 316 PACKYR20 Num 3 1985 Pack-years smoked in prior year: QV 20 317 PACKYR24 Num 3 1988 Pack-years smoked in prior year: QV 24 318 PACKYR28 Num 3 1991 Pack-years smoked in prior year: QV 28 319 PACKYR32 Num 3 1994 Pack-years smoked in prior year: QV 32 320 PACKYR36 Num 3 1997 Pack-years smoked in prior year: QV 36 225 PCT_FAT Num 8 1502 Percent body fat as estimated by BIA 380 PHOS00 Num 8 2422 Dietary phosphorous (mg): baseline 381 PHOS08 Num 8 2430 Dietary phosphorous (mg): QV 08 382 PHOS20 Num 8 2438 Dietary phosphorous (mg): QV 20 343 PHOS99 Num 8 2126 Dietary phosphorous (mg): close-out 283 PIPE_00 Num 8 1791 Pipe or cigar smoker: baseline 303 PIPE_04 Num 8 1901 Pipe or cigar smoker: QV 04 304 PIPE_08 Num 8 1909 Pipe or cigar smoker: QV 08 305 PIPE_12 Num 8 1917 Pipe or cigar smoker: QV 12 306 PIPE_16 Num 8 1925 Pipe or cigar smoker: QV 16 307 PIPE_20 Num 8 1933 Pipe or cigar smoker: QV 20 308 PIPE_24 Num 8 1941 Pipe or cigar smoker: QV 24 309 PIPE_28 Num 8 1949 Pipe or cigar smoker: QV 28 310 PIPE_32 Num 8 1957 Pipe or cigar smoker: QV 32 311 PIPE_36 Num 8 1965 Pipe or cigar smoker: QV 36 359 PLYPCT00 Num 8 2254 Polyunsaturated fat (% kCals): baseline 360 PLYPCT08 Num 8 2262 Polyunsaturated fat (% calories): QV 08 361 PLYPCT20 Num 8 2270 Polyunsaturated fat (% calories): QV 20 336 PLYPCT99 Num 8 2070 Polyunsaturated fat (% kCals): close-out 347 PROCAL00 Num 8 2158 Dietary protein as % calories: baseline 348 PROCAL08 Num 8 2166 Dietary protein as % calories: QV 08 349 PROCAL20 Num 8 2174 Dietary protein as % calories: QV 20 332 PROCAL99 Num 8 2038 Dietary protein as % calories: close-out 371 PROTWT00 Num 8 2350 Protein (g/kg body weight): baseline 372 PROTWT08 Num 8 2358 Protein (g/kg body weight): QV 08 373 PROTWT20 Num 8 2366 Protein (g/kg body weight): QV 20 340 PROTWT99 Num 8 2102 Protein (g/kg body weight): close-out 447 QV1TRIG2 Num 3 2687 Single trig > 200: QV of event/censoring 461 QV1TRIG4 Num 3 2729 Single trig > 400: QV of event/censoring 419 QVOVERWT Num 3 2603 Overweight (NCHS): QV of event/censoring 445 QVSTRIG2 Num 3 2681 Sustained trig > 200: QV event/censoring 459 QVSTRIG4 Num 3 2723 Sustained trig > 400: QV event/censoring 475 QV_1HDL Num 3 2771 Single HDL <= 35: QV of event/censoring 433 QV_1LDL Num 3 2645 Single LDL => 130: QV of event/censoring 14 QV_HCHOL Num 3 89 Hypercholest.: QV of event or censoring 12 QV_HTEN Num 3 83 Hypertension: QV of event or censoring 16 QV_HTRIG Num 3 95 Hypertriglyc.: QV of event or censoring 407 QV_MWG Num 3 2567 Major wt. gain: QV of event or censoring 395 QV_OBESE Num 3 2531 Weight > 120% ideal: QV event/censoring 473 QV_SHDL Num 3 2765 Sustained HDL <= 35: QV event/censoring 431 QV_SLDL Num 3 2639 Sustained LDL => 130: QV event/censoring 229 RACE Num 3 1519 Race 388 RETBASE Char 4 2491 Baseline retinopathy stratum (Prim/Scnd) The SAS System 31 11:32 Tuesday, December 17, 2002 CONTENTS PROCEDURE # Variable Type Len Pos Format Label -------------------------------------------------------------------------------- 353 SATCAL00 Num 8 2206 Saturated fat as % of calories: baseline 354 SATCAL08 Num 8 2214 Saturated fat as % total calories: QV 08 355 SATCAL20 Num 8 2222 Saturated fat as % to